Auddia

Auddia Inc is a technology company that is engaged in radio broadcasts and streaming audio content digitally. Its products include Auddia App which is a subscription-based commercial-free AM/FM software application, and0 Vodacast is an interactive podcasting platform and application. The company generates revenue through subscription fees from customers accessing the company's cloud-based computing services and advertisement services.

Auddia Inc. - Warrants

Invitation Homes (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INVH#NYSE">INVH</a>) reported quarterly earnings of $0.37 per share. This is a 15.62 percent increase over earnings of $0.32 per share from the same period last year. The company reported quarterly sales of $492.00 million which beat the analyst consensus estimate of $480.67 million by 2.36 percent. This is a 9.39 percent increase over sales of $449.75 million the same period last year.

Earnings

News

INVH

Invitation Homes Q2 FFO $0.37 Up From $0.32 YoY, Sales $492.00M Beat $480.67M Estimate

Sunnova Energy Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOVA#NYSE">NOVA</a>) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.17) by 235.29 percent. This is a 90 percent decrease over losses of $(0.30) per share from the same period last year. The company reported quarterly sales of $66.56 million which beat the analyst consensus estimate of $57.17 million by 16.42 percent. This is a 55.54 percent increase over sales of $42.79 million the same period last year.

NOVA

Sunnova Energy Intl Q2 EPS $(0.57) Misses $(0.17) Estimate, Adj. EBITDA $30.1M, Sales $66.56M Beat $57.17M Estimate

Brookline Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRKL#NASDAQ">BRKL</a>) reported quarterly earnings of $0.40 per share which beat the analyst consensus estimate of $0.31 by 29.03 percent. This is a 60 percent increase over earnings of $0.25 per share from the same period last year. The company reported quarterly sales of $71.11 million which beat the analyst consensus estimate of $70.68 million by 0.60 percent. This is a 10.61 percent increase over sales of $64.29 million the same period last year.

BRKL

Brookline Bancorp Q2 EPS $0.40 Beats $0.31 Estimate, Sales $71.11M Beat $70.68M Estimate

Fortune Brands Home (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FBHS#NYSE">FBHS</a>) reported quarterly earnings of $1.56 per share which beat the analyst consensus estimate of $1.39 by 12.23 percent. This is a 65.96 percent increase over earnings of $0.94 per share from the same period last year. The company reported quarterly sales of $1.94 billion which beat the analyst consensus estimate of $1.89 billion by 2.43 percent. This is a 40.70 percent increase over sales of $1.38 billion the same period last year.

FBHS

Fortune Brands Home Q2 Adj. EPS $1.56 Beats $1.39 Estimate, Sales $1.94B Beat $1.89B Estimate

Aterian Investment Partners, a private investment firm, through its portfolio company Xpress Global Systems LLC, has acquired Delta Distribution/Michigan Carpet, a specialized flooring less-than-truckload company headquartered in Grand Rapids, Michigan. 

The deal was announced Wednesday. No financial terms were disclosed.

XGS, based in Chattanooga, Tennessee, hopes the merger of the two companies will strengthen its overall operational footprint while building on the strategic growth objective.

<hr />

<img alt="" src="https://s29755.pcdn.co/wp-content/uploads/2021/07/marketexperts-1200x215.jpeg" />

<h3 id="h-quick-analysis-from-our-market-experts">Quick Analysis From Our Market Experts</h3>

<blockquote>
Delta Distribution/Michigan Carpet was the biggest floor covering (carpet mainly) LTL provider in the upper Midwest after Watkins Sheppard exited. The company was able to undercut XGS rates and service to an extent because of its focused distribution channel in Michigan, Indiana and Ohio. This acquisition effectively removes the largest competitor in the area for XGS. 
</blockquote>

<blockquote>
Previous acquisition 7 Hills was a carpet consolidator focused largely in Texas. Much smaller than Michigan/Delta — but again this removes a decent-sized regional competitor from the market for XGS. 
</blockquote>

<blockquote>
Bottom line: These are good acquisitions for Xpress Global, removing some well-established competition from its path. There is little to no growth expected over the next several years for carpet sales, and attaining market share and pricing power is probably the best growth strategy considering diversification to square or palletized freight is extremely difficult. Rolled goods do not mix well with palletized freight on a trailer and requires specialized equipment for loading/unloading. Also, the competition is much stiffer. 
</blockquote>

<hr />

"Our acquisition of Delta Distribution complements the overall business offerings of XGS and again marks another meaningful evolution of our portfolio," said Dan Martin, CEO of XGS. "Delta is a very well-run company that expands our network in the Midwest region and creates significant value for our stakeholders."

Delta Distribution has been servicing Kentucky, Illinois, Indiana, Ohio, Missouri and Michigan since 1997. It operates 52 late-model company tractors and 185 carpet-spec trailers and has trailer swap programs with major north Georgia carpet mills.

It's the second acquisition by XGS in the past month as the company continues its momentum in the logistics industry. In early July, XGS announced the acquisition of 7 Hills Transport, an asset-based carrier headquartered in Cartersville, Georgia. 

Aterian Investment Partners manages over $700 million of committed capital and invests in industry-leading, middle-market businesses.
Image by <a href="https://pixabay.com/users/chapay-565264/?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=2677373">chapay</a> from <a href="https://pixabay.com/?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=2677373">Pixabay</a>

Commodities

Markets

General

Xpress Global Systems acquires LTL Delta Distribution

CMPR

Cimpress Q4 Adj. EBITDA $62.198M vs $63.838M In Same Qtr. Last Year

Cincinnati Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CINF#NASDAQ">CINF</a>) reported quarterly earnings of $1.79 per share which beat the analyst consensus estimate of $0.94 by 90.43 percent. This is a 306.82 percent increase over earnings of $0.44 per share from the same period last year.

CINF

Cincinnati Financial Q2 EPS $1.79 Beats $0.94 Estimate

Guidance

ALGN

Align Technology Raises Guidance

DNMR

Danimer Scientific to Acquire Novomer For $152M

Cimpress (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPR#NASDAQ">CMPR</a>) reported quarterly sales of $641.02 million which beat the analyst consensus estimate of $614.66 million by 4.29 percent. This is a 49.38 percent increase over sales of $429.11 million the same period last year.

CORRECTION: Cimpress Q4 Sales $641.02M Beat $614.66M Estimate

Pegasystems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGA#NASDAQ">PEGA</a>) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.18) by 27.78 percent. This is a 17.86 percent increase over losses of $(0.28) per share from the same period last year. The company reported quarterly sales of $325.70 million which beat the analyst consensus estimate of $273.14 million by 19.24 percent. This is a 43.24 percent increase over sales of $227.38 million the same period last year.

PEGA

Pegasystems Q2 Adj. EPS $(0.23) Misses $(0.18) Estimate, Sales $325.70M Beat $273.14M Estimate

Management

BANC

Banc Of California Announced It Has Appointed Diana Hanson As Senior Vice President And Chief Accounting Officer Of The Company And Bank, Effective August 16, 2021.

Cimpress (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPR#NASDAQ">CMPR</a>) reported quarterly sales of $674.71 million which beat the analyst consensus estimate of $614.66 million by 9.77 percent. This is a 57.24 percent increase over sales of $429.11 million the same period last year.

Cimpress Q4 Sales $674.71M Beat $614.66M Estimate

Marker Therapeutics, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRKR#NASDAQ">MRKR</a>), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced that the Company&#39;s new cGMP manufacturing facility in&nbsp;Houston, TX, located near the George Bush Intercontinental Airport, is fully operational. The facility will manufacture Marker&#39;s MultiTAA-specific T cell products for the Company&#39;s Phase 2 acute myeloid leukemia (AML) trial as well as future hematological and solid tumor trials, in addition to producing the potential commercial supply of any approved products.

Biotech

MRKR

Marker Therapeutics Announces Opening Of New cGMP Manufacturing Facility

Shares of Biomarin Pharmaceutical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMRN#NASDAQ">BMRN</a>) were flat in after-market trading after the company reported Q2 results.
<h2>Quarterly Results</h2>
Earnings per share rose 143.75% over the past year to $0.07, which beat the estimate of ($0.11).
Revenue of $501,693,000 higher by 16.81% year over year, which beat the estimate of $448,790,000.
<h2>Looking Ahead</h2>
Biomarin Pharmaceutical hasn&#39;t issued any earnings guidance for the time being.
The upcoming fiscal year&#39;s revenue expected to be between $1,790,000,000 and $1,880,000,000.
<h2>Conference Call Details</h2>
Date: Jul 28, 2021
Time: 04:30 PM
ET Webcast URL: https://onlinexperiences.com/scripts/Server.nxp?LASCmd=AI:4;F:QS!10100&amp;ShowUUID=F1263B20-BE46-4ECA-876D-F6FFD8F51EF3&amp;Referrer=https%3A%2F%2Finvestors.biomarin.com%2F
<h2>Technicals</h2>
Company&#39;s 52-week high was at $124.90
Company&#39;s 52-week low was at $71.35
Price action over last quarter: Up 1.04%
<h2>Company Description</h2>
BioMarin&#39;s focus is on rare-disease therapies. Genzyme (now part of Sanofi) markets Aldurazyme through its joint venture with BioMarin, and BioMarin markets Naglazyme, Vimizim, and Brineura independently. BioMarin also markets Kuvan and Palynziq to treat the rare metabolic disorder PKU (in addition to long-standing U.S. rights, BioMarin has reacquired international rights for Kuvan and Palynziq from Merck KGaA). BioMarin has a hemophilia A gene therapy and a treatment for achondroplasia in late-stage clinical trials.

BMRN

Biomarin Pharmaceutical: Q2 Earnings Insights

Colfax Sees Q3 EPS $0.50-$0.55 Vs. $0.56 Est., Raises FY21 EPS Guidance From $2.05-$2.15 To $2.10-$2.20 Vs. $2.07 Est.

Dividends

Cabot Oil & Gas Corporation Announced It Has Declared A Quarterly Base Dividend Of $0.11 Per Share Of Common Stock. The Dividend Will Be Paid On August 26, 2021 To Shareholders Of Record As Of The Close Of Business On August 12, 2021

Canadian Pacific Railway (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CP#NYSE">CP</a>) reported quarterly earnings of $0.84 per share which beat the analyst consensus estimate of $0.82 by 2.44 percent. This is a 71.43 percent decrease over earnings of $2.94 per share from the same period last year. The company reported quarterly sales of $1.67 billion which beat the analyst consensus estimate of $1.66 billion by 0.72 percent. This is a 29.31 percent increase over sales of $1.29 billion the same period last year.

TSX:CP

Canadian Pacific Railway Q2 Adj. EPS $0.84 Beats $0.82 Estimate, Sales $1.67B Beat $1.66B Estimate

MaxLinear Sees Q3 Sales $215M-$225M vs $202.7M Estimate

WIIM

LRCX

Lam Research shares are trading lower after the company reported Q4 earnings results and issued Q1 2022 guidance.

Auddia shares are trading higher after the company announced the release and national launch of its flagship Auddia app ahead of schedule.

Movers

Trading Ideas

Auddia Shares Halted On Circuit Breaker; Up 40%

Auddia Shares Resume Trading, Move Higher

Intraday Update

Stocks That Hit 52-Week Highs On Tuesday

Following the market opening Tuesday, the Dow traded up 0.40% to 34,420.32 while the NASDAQ fell 0.10% to 14,486.23. The S&amp;P also rose, gaining 0.14% to 4,296.59.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 33,640,570 cases with around 604,110 deaths. India confirmed a total of at least 30,316,890 cases and 397,630 deaths, while Brazil reported over 18,448,400 COVID-19 cases with 514,090 deaths. In total, there were at least 181,437,540 cases of COVID-19 worldwide with more than 3,929,850 deaths, according to data compiled by Johns Hopkins University.

 
Leading and Lagging Sectors

 
Real estate shares jumped by 0.4% on Tuesday. Meanwhile, top gainers in the sector included IRSA Propiedades Comerciales S.A. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRCP#NASDAQ">IRCP</a>), up 2%, and Realogy Holdings Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RLGY#NYSE">RLGY</a>), up 2%.

 
In trading on Tuesday, communication services shares fell 0.5%.

 
Top Headline

FactSet Research Systems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PERI#NASDAQ">PERI</a>) reported downbeat earnings for its third quarter, while sales exceeded views.

FactSet Research reported quarterly adjusted earnings of $2.72 per share, missing analysts&rsquo; estimates of $2.74 per share. The company&rsquo;s quarterly sales came in at $399.60 million, versus analysts&rsquo; expectations of $397.92 million.

FactSet said it sees FY21 adjusted EPS of $10.75-$11.15, versus analysts&rsquo; estimates of $11.14. The company projects FY21 sales of $1.57 billion-$1.585 billion, versus expectations of $1.58 billion.

 
Equities Trading UP

 
Cerevel Therapeutics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERE#NASDAQ">CERE</a>) shares shot up 96% to $24.69 after the company announced positive results from its Phase 1b clinical trial of CVL-231 in adult patients with schizophrenia. CVL-231 was generally well-tolerated, and discontinuation rates were similar between CVL-231 and placebo in the six weeks of dosing, at 22% each.

 
Shares of BSQUARE Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSQR#NASDAQ">BSQR</a>) got a boost, shooting 67% to $4.38 after gaining over 8%on Monday.

 
Auddia Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) shares were also up, gaining 35% to $7.96 after the company announced the release and national launch of its flagship Auddia app ahead of schedule.

<a href="https://www.benzinga.com/movers">Check out these big movers of the day</a>

 
Equities Trading DOWN

Better Choice Company Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTTR#NYSE">BTTR</a>) shares tumbled 34% to $4.87 after the company reported the pricing of its underwritten public offering of 8,000,000 shares at $5.00 per share.

Shares of DiaMedica Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DMAC#NASDAQ">DMAC</a>) were down 32% to $4.89 after the company announced positive interim results from its Phase 2 REDUX trial of DM199 in chronic kidney disease. DM199, the company noted, is demonstrating clinically meaningful improvements in kidney function in Cohorts 1 and 2, as measured by a simultaneously stabilizing estimated glomerular filtration rate and decreasing urine albumin-to-creatinine ratio.

MediWound Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDWD#NASDAQ">MDWD</a>) was down, falling 31% to $3.88. Vericel&rsquo;s development partner, MediWound, received a complete response letter from FDA regarding the NexoBrid application seeking approval for eschar removal in adults with deep partial-thickness or full-thickness burns.

 
Commodities

In commodity news, oil traded up 0.6% to $73.33,&nbsp;while gold traded down 1.4% to $1,755.80.

&nbsp;

Silver traded down 1.8% Tuesday to $25.76&nbsp;while copper fell 0.6% to $4.2535.

 
Euro zone

European shares were mostly higher today. The eurozone&rsquo;s STOXX 600 gained 0.41%, the Spanish Ibex Index fell 0.02% and the German DAX 30 gained 1.01%. Meanwhile, the London&rsquo;s FTSE 100 rose 0.38%, French CAC 40 gained 0.28% and Italy&rsquo;s&nbsp;FTSE MIB gained 0.51%.

Spain&#39;s consumer price inflation rate fell to 2.6% year-over-year in June from 2.7% a month ago, while retail sales climbed 19.6% from a year ago in May. French consumer confidence rose to 102 in June from 98 in the prior month.

Annual house price growth in the UK increased to 13.4% in June. Consumer credit in the UK rose by GBP 0.28 billion in May, while the country&rsquo;s factories produced 54,962 cars during May compared to 5,314 in the year-ago period.

 
Economics

 
The S&amp;P CoreLogic Case-Shiller 20-city home price index surged 14.9% in April versus a 13.4% rise in the earlier month.

 
The FHFA house price index rose 1.8% in April.

 
The Conference Board&rsquo;s consumer confidence index jumped to 127.3 in June from previous reading of 120.

 
The American Petroleum Institute&rsquo;s report on crude oil stocks is scheduled for release at 4:30 p.m. ET.

 
<a href="https://www.benzinga.com/calendar/economics/">Check out the full economic calendar here </a>

Penny Stocks

Eurozone

Small Cap

Global

Mid-Morning Market Update: Markets Mostly Higher; FactSet Research Reports Mixed Q3 Results

<h3>Gainers</h3>

<ul>
	<li>Cerevel Therapeutics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERE#NASDAQ">CERE</a>) shares jumped 111.5% to $26.58 after the company announced positive results from its Phase 1b clinical trial of CVL-231 in adult patients with schizophrenia. CVL-231 was generally well-tolerated, and discontinuation rates were similar between CVL-231 and placebo in the six weeks of dosing, at 22% each.</li>
	<li>BSQUARE Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSQR#NASDAQ">BSQR</a>) climbed 82.4% to $4.78 after gaining over 8%on Monday.</li>
	<li>Marin Software Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) jumped 59.4% to $11.95 after jumping around 97% on Monday. Marin Software, last week, announced it has added the ability to manage Instacart Ads to its flagship MarinOne platform.</li>
	<li>Exela Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XELA#NASDAQ">XELA</a>) jumped 45% to $2.13 after gaining over 5% on Monday.</li>
	<li>Auddia Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) shares jumped 40.7% to $8.29 after the company announced the release and national launch of its flagship Auddia app ahead of schedule.</li>
	<li>Bridgeline Digital, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLIN#NASDAQ">BLIN</a>) gained 24% to $3.07.</li>
	<li>Baosheng Media Group Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BAOS#NASDAQ">BAOS</a>) gained 20.6% to $4.0883.</li>
	<li>Infobird Co., Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IFBD#NASDAQ">IFBD</a>) surged 18.7% to $4.6066.</li>
	<li>Amesite Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMST#NASDAQ">AMST</a>) rose 18% to $3.03.</li>
	<li>Graphite Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRPH#NASDAQ">GRPH</a>) gained 14.2% to $25.93. The company recently priced its IPO at $17 a share.</li>
	<li>Smart Sand, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SND#NASDAQ">SND</a>) gained 13.7% to $3.47. Smart Sand entered into a $35 million&nbsp;settlement with US Well Services, LLC. Evercore ISI Group upgraded Smart Sand from Underperform to In-Line and announced a $4 price target.</li>
	<li>Translate Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBIO#NASDAQ">TBIO</a>) gained 13.1% to $25.79. Sanofi and Translate Bio recently said they have initiated a Phase 1 clinical trial evaluating an mRNA-based investigational vaccine against seasonal influenza.</li>
	<li>Digital Brands Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DBGI#NASDAQ">DBGI</a>) surged 12.2% to $6.16. Digital Brands, on Monday, reported first-quarter FY21 revenue of $408 thousand, down 84% year-on-year.</li>
	<li>Diginex Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EQOS#NASDAQ">EQOS</a>) gained 11.3% to $7.09.</li>
	<li>LMP Automotive Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMPX#NASDAQ">LMPX</a>) jumped 10.8% to $18.29 ahead of quarterly earnings.</li>
	<li>PLBY Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLBY#NASDAQ">PLBY</a>) rose 9.4% to $41.48 after the company announced it will acquire Birdette for $333 million in cash and stock.</li>
	<li>Jefferies Financial Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JEF#NYSE">JEF</a>) shares surged 8.6% to $34.71 after the company reported strong Q2 results and raised its quarterly dividend.</li>
	<li>Universe Pharmaceuticals INC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) shares gained 6.8% to $3.1601 after declining 4% on Monday. Universe Pharmaceuticals, last month, entered into Letter of Intent for strategic cooperation with Kitanihon Pharmaceutical.</li>
	<li>Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) shares rose 4.3% to $91.47 after the company announced it raised its quarterly dividend from $0.35 to $0.70 per share and announced a $12 billion buyback.</li>
</ul>

<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>

<h3>Losers</h3>

<ul>
	<li>Better Choice Company Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTTR#NYSE">BTTR</a>) shares fell 34% to $4.87 after the company reported the pricing of its underwritten public offering of 8,000,000 shares at $5.00 per share.</li>
	<li>DiaMedica Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DMAC#NASDAQ">DMAC</a>) fell 33.2% to $4.79 after the company announced positive interim results from its Phase 2 REDUX trial of DM199 in chronic kidney disease. DM199, the company noted, is demonstrating clinically meaningful improvements in kidney function in Cohorts 1 and 2, as measured by a simultaneously stabilizing estimated glomerular filtration rate and decreasing urine albumin-to-creatinine ratio.</li>
	<li>MediWound Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDWD#NASDAQ">MDWD</a>) fell 29.4% to $3.9801. Vericel&rsquo;s development partner, MediWound, received a complete response letter from FDA regarding the NexoBrid application seeking approval for eschar removal in adults with deep partial-thickness or full-thickness burns.</li>
	<li>ReShape Lifesciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RSLS#NASDAQ">RSLS</a>) dipped 23.8% to $5.82 after the company entered into a warrant exercise transaction for $46.2 million in gross proceeds.</li>
	<li>Celcuity Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELC#NASDAQ">CELC</a>) shares fell 18.7% to $25.15 after the company priced its underwritten public offering of 2,250,000 shares at $25.00 per share.</li>
	<li>X Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYF#NYSE">XYF</a>) dipped 15.9% to $13.85 after gaining over 9% on Monday.</li>
	<li>Sensei Biotherapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNSE#NASDAQ">SNSE</a>) fell 14.8% to $9.24 after the company said it is reprioritizing its pipeline programs to focus on its product candidates, including its multi-antigenic next generation ImmunoPhage candidate, now referred to as SNS-401-NG, and its monoclonal antibody SNS-VISTA candidate. Oppenheimer downgraded Sensei Biotherapeutics from Outperform to Perform.</li>
	<li>Aligos Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGS#NASDAQ">ALGS</a>) fell 13.2% to $20.61 after the company announced a proposed public offering of 4 million shares of common stock.</li>
	<li>Alfi, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALF#NASDAQ">ALF</a>) dropped 12.6% to $16.25.</li>
	<li>Anavex Life Sciences Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVXL#NASDAQ">AVXL</a>) dipped 11.3% to $25.61. Anavex Life Sciences recently announced ANAVEX2-73 improved both primary cognitive and secondary MDS-UPDRS efficacy endpoints with significant biomarker correlation in placebo-controlled Phase 2 clinical trial for treatment of Parkinson&#39;s.</li>
	<li>Virgin Galactic Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPCE#NYSE">SPCE</a>) fell 10.9% to $48.85 as the stock pulled back after spiking last week following FAA approval for its passenger flight license.</li>
	<li>Kiromic BioPharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRBP#NASDAQ">KRBP</a>) fell 10.4% to $7.16 after dropping 20% on Monday.</li>
	<li>LexinFintech Holdings Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LX#NASDAQ">LX</a>) dipped 10.1% to $11.90. The company last week announced a partnership with Huawei.</li>
	<li>Zosano Pharma Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZSAN#NASDAQ">ZSAN</a>) shares fell 7.7% to $0.9320. Zosano Pharma&rsquo;s filing showed registration for $30 million common stock offering.</li>
	<li>Graybug Vision, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRAY#NASDAQ">GRAY</a>) shares fell 7.1% to $5.67 after climbing 17% on Monday.</li>
	<li>Herman Miller, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLHR#NASDAQ">MLHR</a>) dropped 6.5% to $44.83. Herman Miller reported better-than-expected results for its fourth quarter. However, the company issued weak earnings forecast for the current quarter.</li>
</ul>

35 Stocks Moving In Tuesday's Mid-Day Session

Midway through trading Tuesday, the Dow traded up 0.37% to 34,411.60 while the NASDAQ fell 0.03% to 14,495.75. The S&amp;P also rose, gaining 0.16% to 4,297.63.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 33,640,570 cases with around 604,110 deaths. India confirmed a total of at least 30,316,890 cases and 397,630 deaths, while Brazil reported over 18,448,400 COVID-19 cases with 514,090 deaths. In total, there were at least 181,437,540 cases of COVID-19 worldwide with more than 3,929,850 deaths, according to data compiled by Johns Hopkins University.

 
Leading and Lagging Sectors

 
Energy shares jumped by 1% on Tuesday. Meanwhile, top gainers in the sector included Smart Sand, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SND#NASDAQ">SND</a>), up 16%, and Transocean Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIG#NYSE">RIG</a>), up 10%.

 
In trading on Tuesday, communication services shares fell 0.8%.

 
Top Headline

FactSet Research Systems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PERI#NASDAQ">PERI</a>) reported downbeat earnings for its third quarter, while sales exceeded views.

FactSet Research reported quarterly adjusted earnings of $2.72 per share, missing analysts&rsquo; estimates of $2.74 per share. The company&rsquo;s quarterly sales came in at $399.60 million, versus analysts&rsquo; expectations of $397.92 million.

FactSet said it sees FY21 adjusted EPS of $10.75-$11.15, versus analysts&rsquo; estimates of $11.14. The company projects FY21 sales of $1.57 billion-$1.585 billion, versus expectations of $1.58 billion.

 
Equities Trading UP

 
Cerevel Therapeutics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERE#NASDAQ">CERE</a>) shares shot up 103% to $25.50 after the company announced positive results from its Phase 1b clinical trial of CVL-231 in adult patients with schizophrenia. CVL-231 was generally well-tolerated, and discontinuation rates were similar between CVL-231 and placebo in the six weeks of dosing, at 22% each.

 
Shares of Marin Software Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) got a boost, shooting 52% to $11.43 after jumping around 97% on Monday. Marin Software, last week, announced it has added the ability to manage Instacart Ads to its flagship MarinOne platform.

 
Auddia Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) shares were also up, gaining 35% to $7.94 after the company announced the release and national launch of its flagship Auddia app ahead of schedule.

<a href="https://www.benzinga.com/movers">Check out these big movers of the day</a>

 
Equities Trading DOWN

Better Choice Company Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTTR#NYSE">BTTR</a>) shares tumbled 35% to $4.77 after the company reported the pricing of its underwritten public offering of 8,000,000 shares at $5.00 per share.

Shares of DiaMedica Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DMAC#NASDAQ">DMAC</a>) were down 34% to $4.75 after the company announced positive interim results from its Phase 2 REDUX trial of DM199 in chronic kidney disease. DM199, the company noted, is demonstrating clinically meaningful improvements in kidney function in Cohorts 1 and 2, as measured by a simultaneously stabilizing estimated glomerular filtration rate and decreasing urine albumin-to-creatinine ratio.

MediWound Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDWD#NASDAQ">MDWD</a>) was down, falling 28% to $4.05. Vericel&rsquo;s development partner, MediWound, received a complete response letter from FDA regarding the NexoBrid application seeking approval for eschar removal in adults with deep partial-thickness or full-thickness burns.

 
Commodities

 
In commodity news, oil traded up 0.6% to $73.33, while gold traded down 1.4% to $1,755.80.

 
Silver traded down 1.8% Tuesday to $25.76 while copper fell 0.6% to $4.2535.

 
Euro zone

European shares were mostly higher today. The eurozone&rsquo;s STOXX 600 gained 0.41%, the Spanish Ibex Index fell 0.02% and the German DAX 30 gained 1.01%. Meanwhile, the London&rsquo;s FTSE 100 rose 0.38%, French CAC 40 gained 0.28% and Italy&rsquo;s FTSE MIB gained 0.51%.

Spain&#39;s consumer price inflation rate fell to 2.6% year-over-year in June from 2.7% a month ago, while retail sales climbed 19.6% from a year ago in May. French consumer confidence rose to 102 in June from 98 in the prior month.

Annual house price growth in the UK increased to 13.4% in June. Consumer credit in the UK rose by GBP 0.28 billion in May, while the country&rsquo;s factories produced 54,962 cars during May compared to 5,314 in the year-ago period.

 
Economics

 
The S&amp;P CoreLogic Case-Shiller 20-city home price index surged 14.9% in April versus a 13.4% rise in the earlier month.

 
The FHFA house price index rose 1.8% in April.

 
The Conference Board&rsquo;s consumer confidence index jumped to 127.3 in June from previous reading of 120.

 
The American Petroleum Institute&rsquo;s report on crude oil stocks is scheduled for release at 4:30 p.m. ET.

 
<a href="https://www.benzinga.com/calendar/economics/">Check out the full economic calendar here </a>

Mid-Day Market Update: Gold Drops Over 1%; Cerevel Therapeutics Shares Spike Higher

&nbsp;

<h3>Gainers</h3>

<ul>
	<li>BSQUARE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSQR#NASDAQ">BSQR</a>) stock increased by 99.61% to $5.23 during Tuesday&#39;s regular session. BSQUARE&#39;s stock is trading at a volume of 94.0 million shares as of 12:30 EST. This is 21697.98% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $70.1 million.</li>
	<li>Marin Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) shares rose 73.33% to $13.0. As of 12:30 EST, this security is trading at a volume of 215.6 million shares, making up 2309.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $142.5 million.</li>
	<li>Exela Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XELA#NASDAQ">XELA</a>) stock increased by 41.83% to $2.08. Trading volume for Exela Technologies&#39;s stock is 233.2 million as of 12:30 EST. This is 9293.21% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $123.4 million.</li>
	<li>Infobird Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IFBD#NASDAQ">IFBD</a>) stock increased by 37.57% to $5.34. As of 12:30 EST, this security is trading at a volume of 22.0 million shares, making up 1694.34% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $134.7 million.</li>
	<li>Powerbridge Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBTS#NASDAQ">PBTS</a>) stock increased by 32.86% to $1.9. Powerbridge Technologies&#39;s stock is trading at a volume of 5.4 million shares as of 12:30 EST. This is 538.23% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $87.1 million.</li>
	<li>Auddia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) shares moved upwards by 22.57% to $7.22. Trading volume for this security as of 12:30 EST is 52.4 million, which is 4194.12% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $81.5 million.</li>
</ul>

&nbsp;

&nbsp;

<h3>Losers</h3>

&nbsp;

<ul>
	<li>Cemtrex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETXP#NASDAQ">CETXP</a>) shares fell 16.61% to $2.21 during Tuesday&#39;s regular session. Trading volume for this security as of 12:30 EST is 1.0K, which is 59.84% of its average full-day volume over the last 100 days.</li>
	<li>BTRS Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTRS#NASDAQ">BTRS</a>) stock fell 10.63% to $12.28. The current volume of 536.6K shares is 62.16% of BTRS Holdings&#39;s average full-day volume over the last 100 days (last updated at 12:30 EST). The company&#39;s market cap stands at $1.9 billion.</li>
	<li>ALFI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALF#NASDAQ">ALF</a>) shares declined by 8.45% to $17.02. As of 12:30 EST, this security is trading at a volume of 5.8 million shares, making up 25.98% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $242.5 million.</li>
	<li>Atomera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATOM#NASDAQ">ATOM</a>) shares declined by 8.28% to $21.72. As of 12:30 EST, this security is trading at a volume of 339.3K shares, making up 59.87% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $500.3 million.</li>
	<li>SilverSun Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSNT#NASDAQ">SSNT</a>) stock decreased by 6.47% to $11.06. Trading volume for SilverSun Technologies&#39;s stock is 137.6K as of 12:30 EST. This is 61.76% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $55.9 million.</li>
	<li>Deswell Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSWL#NASDAQ">DSWL</a>) shares decreased by 6.19% to $4.85. As of 12:30 EST, this security is trading at a volume of 56.9K shares, making up 168.13% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $77.1 million.</li>
</ul>

&nbsp;

&nbsp;

12 Information Technology Stocks Moving In Tuesday's Intraday Session

Toward the end of trading Tuesday, the Dow traded up 0.04% to 34,295.41 while the NASDAQ rose 0.13% to 14,518.98. The S&amp;P traded flat at 4,290.65.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 33,640,570 cases with around 604,110 deaths. India confirmed a total of at least 30,316,890 cases and 397,630 deaths, while Brazil reported over 18,448,400 COVID-19 cases with 514,090 deaths. In total, there were at least 181,437,540 cases of COVID-19 worldwide with more than 3,929,850 deaths, according to data compiled by Johns Hopkins University.

 
Leading and Lagging Sectors

 
Information technology shares jumped by 0.6% on Tuesday. Meanwhile, top gainers in the sector included DoubleVerify Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DV#NYSE">DV</a>), up 9%, and SGOCO Group, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGOC#NASDAQ">SGOC</a>), up 11%.

 
In trading on Tuesday, utilities shares fell 1.3%.

 
Top Headline

FactSet Research Systems Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDS#NYSE">FDS</a>) reported downbeat earnings for its third quarter, while sales exceeded views.

FactSet Research reported quarterly adjusted earnings of $2.72 per share, missing analysts&rsquo; estimates of $2.74 per share. The company&rsquo;s quarterly sales came in at $399.60 million, versus analysts&rsquo; expectations of $397.92 million.

FactSet said it sees FY21 adjusted EPS of $10.75-$11.15, versus analysts&rsquo; estimates of $11.14. The company projects FY21 sales of $1.57 billion-$1.585 billion, versus expectations of $1.58 billion.

 
Equities Trading UP

 
Cerevel Therapeutics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERE#NASDAQ">CERE</a>) shares shot up 109% to $26.31 after the company announced positive results from its Phase 1b clinical trial of CVL-231 in adult patients with schizophrenia. CVL-231 was generally well-tolerated, and discontinuation rates were similar between CVL-231 and placebo in the six weeks of dosing, at 22% each.

 
Shares of Marin Software Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) got a boost, shooting 72% to $12.88 after jumping around 97% on Monday. Marin Software, last week, announced it has added the ability to manage Instacart Ads to its flagship MarinOne platform.

 
Auddia Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) shares were also up, gaining 24% to $7.28 after the company announced the release and national launch of its flagship Auddia app ahead of schedule.

<a href="https://www.benzinga.com/movers">Check out these big movers of the day</a>

 
Equities Trading DOWN

Better Choice Company Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTTR#NYSE">BTTR</a>) shares tumbled 39% to $4.49 after the company reported the pricing of its underwritten public offering of 8,000,000 shares at $5.00 per share.

Shares of DiaMedica Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DMAC#NASDAQ">DMAC</a>) were down 33% to $4.80 after the company announced interim results from its Phase 2 REDUX trial of DM199 in chronic kidney disease. DM199, the company noted, is demonstrating clinically meaningful improvements in kidney function in Cohorts 1 and 2, as measured by a simultaneously stabilizing estimated glomerular filtration rate and decreasing urine albumin-to-creatinine ratio.

MediWound Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDWD#NASDAQ">MDWD</a>) was down, falling 26% to $4.15. Vericel&rsquo;s development partner, MediWound, received a complete response letter from FDA regarding the NexoBrid application seeking approval for eschar removal in adults with deep partial-thickness or full-thickness burns.

 
Commodities

 
In commodity news, oil traded up 0.2% to $73.07, while gold traded down 1.1% to $1,762.00.

 
Silver traded down 1.4% Tuesday to $25.845 while copper fell 0.4% to $4.2590.

 
Euro zone

European shares closed higher today. The eurozone&rsquo;s STOXX 600 gained 0.31%, the Spanish Ibex Index rose 0.02% and the German DAX 30 gained 0.88%. Meanwhile, the London&rsquo;s FTSE 100 rose 0.21%, French CAC 40 gained 0.14% and Italy&rsquo;s FTSE MIB gained 0.52%.

Spain&#39;s consumer price inflation rate fell to 2.6% year-over-year in June from 2.7% a month ago, while retail sales climbed 19.6% from a year ago in May. French consumer confidence rose to 102 in June from 98 in the prior month.

Annual house price growth in the UK increased to 13.4% in June. Consumer credit in the UK rose by GBP 0.28 billion in May, while the country&rsquo;s factories produced 54,962 cars during May compared to 5,314 in the year-ago period.

 
Economics

 
The S&amp;P CoreLogic Case-Shiller 20-city home price index surged 14.9% in April versus a 13.4% rise in the earlier month.

 
The FHFA house price index rose 1.8% in April.

 
The Conference Board&rsquo;s consumer confidence index jumped to 127.3 in June from previous reading of 120.

 
The American Petroleum Institute&rsquo;s report on crude oil stocks is scheduled for release at 4:30 p.m. ET.

 
<a href="https://www.benzinga.com/calendar/economics/">Check out the full economic calendar here </a>

Mid-Afternoon Market Update: US Stocks Mostly Flat; DiaMedica Therapeutics Shares Plunge

<h3>Gainers</h3>
<ul>
<li>Powerbridge Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBTS#NASDAQ">PBTS</a>) shares rose 43.7% to $4.11 during Tuesday's after-market session. Trading volume for this security closed at 2.3 million, accounting for 231.56% of its average full-day volume over the last 100 days. The company's market cap stands at $188.4 million. </li>
<li>UTStarcom Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UTSI#NASDAQ">UTSI</a>) shares moved upwards by 17.64% to $1.8. UTStarcom Holdings's trading volume hit 1.0 million shares by close, accounting for 218.42% of its average volume over the last 100 days. The company's market cap stands at $65.1 million. </li>
<li>Evolving Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVOL#NASDAQ">EVOL</a>) shares rose 7.22% to $2.97. This security traded at a volume of 9.4K shares come close, making up 5.56% of its average volume over the last 100 days. The company's market cap stands at $36.3 million. </li>
<li>Bridgeline Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLIN#NASDAQ">BLIN</a>) stock rose 6.04% to $3.6. This security traded at a volume of 61.6K shares come close, making up 52.25% of its average volume over the last 100 days. The market value of their outstanding shares is at $23.1 million. </li>
<li>Frequency Electronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEIM#NASDAQ">FEIM</a>) stock increased by 5.47% to $10.02. Today's trading volume for this security ended up closing at 2.7K shares, which is 13.25 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $92.1 million. The company's, Q4 earnings came out today. </li>
<li>Cohu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COHU#NASDAQ">COHU</a>) shares moved upwards by 4.12% to $38.09. At the close, Cohu's trading volume reached 30.5K shares. This is 5.35% of its average volume over the last 100 days. The company's market cap stands at $1.8 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Qumu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUMU#NASDAQ">QUMU</a>) stock declined by 11.17% to $3.42 during Tuesday's after-market session. Qumu's trading volume hit 62.3K shares by close, accounting for 34.61% of its average volume over the last 100 days. The company's market cap stands at $60.1 million. As per the press release, Q2 earnings came out today. </li>
<li>BSQUARE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSQR#NASDAQ">BSQR</a>) stock declined by 8.96% to $7.32. Trading volume for this security closed at 3.0 million, accounting for 692.25% of its average full-day volume over the last 100 days. The company's market cap stands at $98.1 million. </li>
<li>Grid Dynamics Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDYN#NASDAQ">GDYN</a>) shares declined by 8.32% to $16.09. This security traded at a volume of 7.3K shares come close, making up 4.46% of its average volume over the last 100 days. The market value of their outstanding shares is at $871.6 million. </li>
<li>Marin Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) shares decreased by 7.06% to $16.08. This security traded at a volume of 4.5 million shares come close, making up 49.16% of its average volume over the last 100 days. The market value of their outstanding shares is at $176.3 million. </li>
<li>My Size (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYSZ#NASDAQ">MYSZ</a>) stock declined by 3.48% to $1.39. Trading volume for this security closed at 772, accounting for 0.18% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $20.9 million. </li>
<li>Auddia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) stock decreased by 2.72% to $6.82. Auddia's trading volume hit 155.4K shares by close, accounting for 12.44% of its average volume over the last 100 days. The market value of their outstanding shares is at $77.0 million. </li>
</ul>

12 Information Technology Stocks Moving In Tuesday's After-Market Session

Gainers

<ul>
	<li>BSQUARE Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSQR#NASDAQ">BSQR</a>) shares jumped 206.9% to close at $8.04 on Tuesday on abnormally-high volume possibly amid increased attention from retail investors. Bsquare is a software development firm that is both Microsoft-embedded and an IoT partner.</li>
	<li>Cerevel Therapeutics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERE#NASDAQ">CERE</a>) shares surged 136.2% to close at $29.69 on Tuesday after the company announced positive results from its Phase 1b clinical trial of CVL-231 in adult patients with schizophrenia. CVL-231 was generally well-tolerated, and discontinuation rates were similar between CVL-231 and placebo in the six weeks of dosing, at 22% each.</li>
	<li>Marin Software Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) climbed 130.7% to settle at $17.30 after jumping around 97% on Monday. Marin Software, last week, announced it has added the ability to manage Instacart Ads to its flagship MarinOne platform.</li>
	<li>Exela Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XELA#NASDAQ">XELA</a>) climbed 59.2% to close at $2.34 after gaining over 5% on Monday.</li>
	<li>Bridgeline Digital, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLIN#NASDAQ">BLIN</a>) jumped 36.7% to settle at $3.39.</li>
	<li>Infobird Co., Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IFBD#NASDAQ">IFBD</a>) jumped 30.7% to settle at $5.07.</li>
	<li>Universe Pharmaceuticals INC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) shares climbed 25% to close at $3.70 after declining 4% on Monday. Universe Pharmaceuticals, last month, entered into Letter of Intent for strategic cooperation with Kitanihon Pharmaceutical.</li>
	<li>Graphite Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRPH#NASDAQ">GRPH</a>) climbed 21.6% to settle at $27.60. The company recently priced its IPO at $17a share.</li>
	<li>The OLB Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLB#NASDAQ">OLB</a>) surged 21.1% to close at $6.49.</li>
	<li>Amesite Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMST#NASDAQ">AMST</a>) gained 21% to close at $3.11.</li>
	<li>Troika Media Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRKA#NASDAQ">TRKA</a>) surged 20.6% to close at $3.45.</li>
	<li>Verve Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERV#NASDAQ">VERV</a>) jumped 20.6% to settle at $54.25.</li>
	<li>Sphere 3D Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANY#NASDAQ">ANY</a>) jumped 19.8% to close at $3.09.</li>
	<li>Evolving Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVOL#NASDAQ">EVOL</a>) surged 19.4% to settle at $2.77.</li>
	<li>Quhuo Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QH#NASDAQ">QH</a>) surged 19.2% to settle at $4.10.</li>
	<li>Auddia Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) shares gained 19% to close at $7.01 after the company announced the release and national launch of its flagship Auddia app ahead of schedule.</li>
	<li>Greenlane Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) gained 17% to close at $4.82.</li>
	<li>Nephros, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEPH#NASDAQ">NEPH</a>) rose 16.8% to close at $10.68.</li>
	<li>XOMA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XOMA#NASDAQ">XOMA</a>) surged 16.6% to settle at $37.68. Aegis Capital initiated coverage on XOMA with a Buy rating and announced a price target of $60.</li>
	<li>Holicity Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOL#NASDAQ">HOL</a>) gained 15.9% to settle at $13.33.</li>
	<li>Alzamend Neuro, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALZN#NASDAQ">ALZN</a>) surged 15.2% to close at $11.06.</li>
	<li>Baosheng Media Group Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BAOS#NASDAQ">BAOS</a>) rose 14.8% to settle at $3.89.</li>
	<li>Bon Natural Life Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BON#NASDAQ">BON</a>) surged 14.7% to close at $7.90. The company recently priced its IPO at $5 per share.</li>
	<li>Intellia Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTLA#NASDAQ">NTLA</a>) rose 13.6% to close at $151.61. Intellia Therapeutics commenced an underwritten public offering of $400 million shares of its common stock.</li>
	<li>Red Cat Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCAT#NASDAQ">RCAT</a>) gained 13.5% to settle at $2.85.</li>
	<li>Century Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPSC#NASDAQ">IPSC</a>) rose 13.4% to close at $27.63. The company recently priced its IPO at $20 a share.</li>
	<li>Translate Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBIO#NASDAQ">TBIO</a>) gained 12.5% to close at $25.66. Sanofi and Translate Bio recently said they have initiated a Phase 1 clinical trial evaluating an mRNA-based investigational vaccine against seasonal influenza.</li>
	<li>Global Internet of People, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDH#NASDAQ">SDH</a>) surged 11.1% to settle at $3.20.</li>
	<li>Smart Sand, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SND#NASDAQ">SND</a>) rose 8.2% to close at $3.30. Smart Sand entered into a $35M settlement with US Well Services, LLC. Evercore ISI Group upgraded Smart Sand from Underperform to In-Line and announced a $4 price target.</li>
	<li>Diginex Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EQOS#NASDAQ">EQOS</a>) climbed 8.2% to close at $6.89.</li>
	<li>LMP Automotive Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMPX#NASDAQ">LMPX</a>) gained 7.1% to close at $17.67 ahead of quarterly earnings.</li>
	<li>Jefferies Financial Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JEF#NYSE">JEF</a>) shares surged 7.1% to settle at $34.22 after the company reported strong Q2 results and raised its quarterly dividend.</li>
	<li>Digital Brands Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DBGI#NASDAQ">DBGI</a>) gained 5.3% to close at $5.78. Digital Brands, on Monday, reported first-quarter FY21 revenue of $408 thousand, down 84% year-on-year.</li>
	<li>Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) shares rose 3.4% to close at $90.64 after the company announced it raised its quarterly dividend from $0.35 to $0.70 per share and announced a $12 billion buyback.</li>
</ul>

<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>

<h3>Losers</h3>

<ul>
	<li>Better Choice Company Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTTR#NYSE">BTTR</a>) shares dipped 44.3% to close at $4.11 on Tuesday after the company reported the pricing of its underwritten public offering of 8,000,000 shares at $5.00 per share.</li>
	<li>DiaMedica Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DMAC#NASDAQ">DMAC</a>) fell 33.9% to close at $4.74 after the company announced positive interim results from its Phase 2 REDUX trial of DM199 in chronic kidney disease. DM199, the company noted, is demonstrating clinically meaningful improvements in kidney function in Cohorts 1 and 2, as measured by a simultaneously stabilizing estimated glomerular filtration rate and decreasing urine albumin-to-creatinine ratio.</li>
	<li>MediWound Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDWD#NASDAQ">MDWD</a>) declined 27.8% to close at $4.07. Vericel&rsquo;s development partner, MediWound, received a complete response letter from FDA regarding the NexoBrid application seeking approval for eschar removal in adults with deep partial-thickness or full-thickness burns.</li>
	<li>ReShape Lifesciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RSLS#NASDAQ">RSLS</a>) fell 27.8% to close at $5.52 after the company enters into a warrant exercise transaction for $46.2 million in gross proceeds.</li>
	<li>Celcuity Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELC#NASDAQ">CELC</a>) shares declined 21.3% to close at $24.33 after the company priced its underwritten public offering of 2,250,000 shares at $25.00 per share.</li>
	<li>Anavex Life Sciences Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVXL#NASDAQ">AVXL</a>) declined 18.1% to close at $23.63. Anavex Life Sciences recently announced ANAVEX2-73 improved both primary cognitive and secondary MDS-UPDRS efficacy endpoints with significant biomarker correlation in placebo-controlled Phase 2 clinical trial for treatment of Parkinson&#39;s.</li>
	<li>AMREP Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXR#NYSE">AXR</a>) fell 17.1% to close at $10.36.</li>
	<li>Kiromic BioPharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRBP#NASDAQ">KRBP</a>) declined 16.9% to close at $6.64 after dropping 20% on Monday.</li>
	<li>Montauk Renewables, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNTK#NASDAQ">MNTK</a>) fell 16.6% to settle at $7.09.</li>
	<li>Sensei Biotherapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNSE#NASDAQ">SNSE</a>) declined 16% to close at $9.10 after the company said it is reprioritizing its pipeline programs to focus on its product candidates, including its multi-antigenic next generation ImmunoPhage candidate, now referred to as SNS-401-NG, and its monoclonal antibody SNS-VISTA candidate. Oppenheimer downgraded Sensei Biotherapeutics from Outperform to Perform.</li>
	<li>Nam Tai Property Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTP#NYSE">NTP</a>) dropped 15.1% to settle at $22.27. Nam Tai Property&rsquo;s shareholder, IsZo Capital, late Sunday issued an update on Nam Tai&#39;s appeal of voided private placement.</li>
	<li>Vericel Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VCEL#NASDAQ">VCEL</a>) shares declined 14.8% to close at $57.77 after MediWound announced it received a Complete Response Letter from the FDA for its NexoBrid Biologics License Application.</li>
	<li>Alfi, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALF#NASDAQ">ALF</a>) fell 14.5% to close at $15.90.</li>
	<li>Virgin Galactic Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPCE#NYSE">SPCE</a>) fell 14.3% to close at $47.02 as the stock pulled back after spiking last week following FAA approval for its passenger flight license.</li>
	<li>Brooklyn ImmunoTherapeutics, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTX#NYSE">BTX</a>) dropped 13.7% to close at $18.43. Brooklyn ImmunoTherapeutics recently executed a non-binding letter of intent to acquire Novellus Therapeutics, a company developing engineered mesenchymal stem cell (MSC) therapies using mRNA cell reprogramming and gene editing technologies licensed from Factor Bioscience.</li>
	<li>Avidity Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNA#NASDAQ">RNA</a>) dipped 12.7% to settle at $22.88.</li>
	<li>Alpha Teknova, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TKNO#NASDAQ">TKNO</a>) shares declined 12.4% to close at $24.51. The company recently priced its IPO at $16 per share.</li>
	<li>The Beachbody Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BODY#NYSE">BODY</a>) shares dropped 12.2% to settle at $11.19.</li>
	<li>Metamaterial Exchangeco Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMAT#NASDAQ">MMAT</a>) fell 11.7% to close at $7.03. Meta Materials recently announced closing of the business combination with Torchlight Energy Resources.</li>
	<li>Aligos Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGS#NASDAQ">ALGS</a>) fell 11% to close at $21.15 after the company announced a proposed public offering of 4 million shares of common stock.</li>
	<li>X Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYF#NYSE">XYF</a>) declined 10.1% to close at $14.80 after gaining over 9% on Monday.</li>
	<li>Herman Miller, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLHR#NASDAQ">MLHR</a>) dropped 6.9% to close at $44.63. Herman Miller reported better-than-expected results for its fourth quarter. However, the company issued weak earnings forecast for the current quarter.</li>
	<li>LexinFintech Holdings Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LX#NASDAQ">LX</a>) fell 5.9% to close at $12.46. The company last week announced a partnership with Huawei.</li>
	<li>Zosano Pharma Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZSAN#NASDAQ">ZSAN</a>) shares fell 4.4% to close at $0.9657. Zosano Pharma&rsquo;s filing showed registration for $30 million common stock offering.</li>
</ul>

Pre-Market Outlook

58 Biggest Movers From Yesterday

<h3>Gainers</h3>

<ul>
	<li>Verb Technology Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERB#NASDAQ">VERB</a>) rose 44.5% to $2.24 in pre-market trading. Verb Technology shares gained over 17% on Tuesday after Ascendiant Capital initiated coverage on the stock with a Buy rating and a $4 price target.</li>
	<li>Bridgeline Digital, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLIN#NASDAQ">BLIN</a>) shares rose 43.7% to $4.87 in pre-market trading. Bridgeline Digital shares jumped over 36% on Tuesday on above-average volume.</li>
	<li>Vertex Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTNR#NASDAQ">VTNR</a>) shares rose 43.4% to $14.73 in pre-market trading after the company agreed To divest used motor oil collection and recycling assets for $140 million to Clean Harbors.</li>
	<li>Borqs Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRQS#NASDAQ">BRQS</a>) rose 34.7% to $1.34 in pre-market trading after gaining 11% on Tuesday. Borqs Technologies recently said it started delivery of cellular CTA-2045 products to SkyCentrics for use by utility companies for smart city deployment.</li>
	<li>Powerbridge Technologies Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBTS#NASDAQ">PBTS</a>) rose 19.6% to $3.42 in pre-market trading after jumping 100% on Tuesday.</li>
	<li>Exela Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XELA#NASDAQ">XELA</a>) rose 16.2% to $2.72 in pre-market trading. Exela Technologies shares jumped over 59% on Tuesday possibly on increased retail investor interest in the stock. Exela Technologies also announced the rollout of EON, its Robotic Process Automation platform for a large health insurance company.</li>
	<li>LMP Automotive Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMPX#NASDAQ">LMPX</a>) rose 16% to $20.50 in pre-market trading after the company swung to a profit in the first quarter.</li>
	<li>HUTCHMED (China) Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCM#NASDAQ">HCM</a>) rose 15.8% to $38.48 in pre-market trading. HUTCHMED and AstraZeneca&#39;s Orpathys recently received conditional approval in China.</li>
	<li>Inpixon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INPX#NASDAQ">INPX</a>) rose 8.8% to $1.24 in pre-market trading. Inpixon was added to Russell Microcap Index, effective June 28.</li>
	<li>MingZhu Logistics Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YGMZ#NASDAQ">YGMZ</a>) rose 8.8% to $4.80 in pre-market trading after the company announced it regained NASDAQ compliance.</li>
	<li>AMMO, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POWW#NASDAQ">POWW</a>) rose 7.7% to $9.47 in pre-market trading after the company reported better-than-expected Q4 results.</li>
	<li>Xcel Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XELB#NASDAQ">XELB</a>) shares rose 6.3% to $2.55 in pre-market trading after gaining over 5% on Tuesday.</li>
</ul>

 
 
Find out what&#39;s going on in today&#39;s market and bring any questions you have to <a href="http://premarket.benzinga.com/pre-market-show/">Benzinga&#39;s PreMarket Prep</a>.

<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>

<h3>Losers</h3>

<ul>
	<li>Altimmune, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALT#NASDAQ">ALT</a>) fell 34.4% to $10.45 in pre-market trading after the company announced it will discontinue further development of AdCOVID and focus resources on obesity and liver programs.</li>
	<li>Kiromic BioPharma, Inc.. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRBP#NASDAQ">KRBP</a>) fell 25.2% to $4.97 in pre-market trading after dropping 17% on Tuesday. The company recently announced it will be presenting at the 2021 Next-Gen Immuno Oncology Congress.</li>
	<li>Panbela Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBLA#NASDAQ">PBLA</a>) shares fell 25.1% to $2.86 in pre-market trading after the company reported a $5 million bought deal offering of common stock.</li>
	<li>Marin Software Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrin#NASDAQ" style="font-size: 13px;">MRIN</a>) fell 20.4% to $13.79 in pre-market trading after jumping over 130% on Tuesday. Marin Software, last week, announced it has added the ability to manage Instacart Ads to its flagship MarinOne platform.</li>
	<li>BSQUARE Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSQR#NASDAQ">BSQR</a>) fell 17.3% to $6.65 in pre-market trading after jumping over 206% on Tuesday.</li>
	<li>electroCore, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ECOR#NASDAQ">ECOR</a>) fell 16.1% to $1.25 in pre-market trading after the company reported a common stock offering.</li>
	<li>Qumu Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUMU#NASDAQ">QUMU</a>) shares fell 16.1% to $3.23 in pre-market trading after the company reported weak preliminary revenue for the second quarter.</li>
	<li>Auddia Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) shares fell 11.1% to $6.23 in pre-market trading. Auddia shares gained 19% on Tuesday after the company announced the release and national launch of its flagship Auddia app ahead of schedule.</li>
	<li>Cerevel Therapeutics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cere#NASDAQ" style="font-size: 13px;">CERE</a>) fell 9.2% to $26.96 in pre-market trading. Cerevel Therapeutics shares jumped 136% on Tuesday after the company announced topline results from Phase 1b trial of CVL-231, saying both doses of CVL-231 demonstrated a clinically meaningful and statistically significant improvement in PANSS Total score.</li>
	<li>MongoDB, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) shares fell 6.5% to $358.60 in pre-market trading after the company priced an underwritten public offering of 2,500,000 shares of its Class A common stock at $365.00 per share.</li>
	<li>Eagle Bulk Shipping Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGLE#NASDAQ">EGLE</a>) shares fell 6.2% to $48.00 in pre-market trading after the company reported the pricing of an underwritten secondary public offering of 1,695,182 shares of common stock at $46.50 per share.</li>
</ul>

23 Stocks Moving in Wednesday's Pre-Market Session

&nbsp;

<h3>Gainers</h3>

<ul>
	<li>Verb Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERB#NASDAQ">VERB</a>) shares moved upwards by 33.54% to $2.07 during Wednesday&#39;s pre-market session. The company&#39;s market cap stands at $131.1 million.</li>
	<li>Bridgeline Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLIN#NASDAQ">BLIN</a>) shares rose 33.33% to $4.52. The company&#39;s market cap stands at $29.1 million.</li>
	<li>Borqs Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRQS#NASDAQ">BRQS</a>) shares moved upwards by 27.62% to $1.27. The market value of their outstanding shares is at $154.7 million.</li>
	<li>Powerbridge Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBTS#NASDAQ">PBTS</a>) stock rose 20.27% to $3.44. The market value of their outstanding shares is at $157.7 million.</li>
	<li>Exela Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XELA#NASDAQ">XELA</a>) shares increased by 17.94% to $2.76. The market value of their outstanding shares is at $163.3 million.</li>
	<li>Inpixon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INPX#NASDAQ">INPX</a>) stock increased by 9.64% to $1.25. The company&#39;s market cap stands at $139.7 million.</li>
</ul>

&nbsp;

&nbsp;

<h3>Losers</h3>

&nbsp;

<ul>
	<li>Marin Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) shares decreased by 20.53% to $13.75 during Wednesday&#39;s pre-market session. The company&#39;s market cap stands at $150.8 million.</li>
	<li>BSQUARE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSQR#NASDAQ">BSQR</a>) shares declined by 17.67% to $6.62. The company&#39;s market cap stands at $88.7 million.</li>
	<li>Qumu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUMU#NASDAQ">QUMU</a>) shares fell 16.11% to $3.23. The company&#39;s market cap stands at $56.8 million.</li>
	<li>Auddia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) shares declined by 11.42% to $6.21. The market value of their outstanding shares is at $70.1 million.</li>
	<li>MongoDB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) stock fell 6.55% to $358.6. The market value of their outstanding shares is at $22.2 billion.</li>
	<li>ALFI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALF#NASDAQ">ALF</a>) shares decreased by 5.35% to $15.05. The market value of their outstanding shares is at $214.4 million.</li>
</ul>

&nbsp;

&nbsp;

12 Information Technology Stocks Moving In Wednesday's Pre-Market Session

<h3>Gainers</h3>

<ul>
	<li>Cuentas Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CUEN#NASDAQ">CUEN</a>) shares jumped 176.6% to $7.69. The stock spiked following a press release saying &quot;WaveMax to Implement the World&#39;s First Shared Wifi6 Network.&quot; Cuentas signed a contract to rollout SharedFi in 170 test locations in the New York City-Tristate area.</li>
	<li>Bridgeline Digital, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLIN#NASDAQ">BLIN</a>) gained 103.5% to $6.90 after jumping over 36% on Tuesday.</li>
	<li>Aerovate Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVTE#NASDAQ">AVTE</a>) surged 74% to $24.27 after the company priced its IPO at $14 per share.</li>
	<li>Dingdong (Cayman) Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDL#NYSE">DDL</a>) shares climbed 66% to $39.34. Dingdong (Cayman) Limited priced its initial public offering of 4 million American depositary shares (ADS) at $23.5 per ADS. The total offering size is $95.7 million.</li>
	<li>Verb Technology Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERB#NASDAQ">VERB</a>) jumped 44.5% to $2.24. Verb Technology shares gained over 17% on Tuesday after Ascendiant Capital initiated coverage on the stock with a Buy rating and a $4 price target.</li>
	<li>Weidai Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WEI#NYSE">WEI</a>) shares jumped 37% to $2.15 after gaining 50% on Tuesday.</li>
	<li>AST SpaceMobile Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) gained 35.5% to $13.83 after Deutsche Bank initiated coverage on the stock with a Buy rating and announced a $35 price target.</li>
	<li>Borqs Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRQS#NASDAQ">BRQS</a>) jumped 34.7% to $1.34 after gaining 11% on Tuesday. Borqs Technologies recently said it started delivery of cellular CTA-2045 products to SkyCentrics for use by utility companies for smart city deployment.</li>
	<li>Intellia Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTLA#NASDAQ">NTLA</a>) gained 29% to $195.46 after the company priced a previously announced public offering at $145 per share, representing a discount of 4.4% from the last close price of $151.6 on Tuesday.</li>
	<li>HUTCHMED (China) Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCM#NASDAQ">HCM</a>) gained 21% to $40.20. HUTCHMED and AstraZeneca&#39;s Orpathys recently received conditional approval in China.</li>
	<li>Vertex Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTNR#NASDAQ">VTNR</a>) shares gained 20.2% to $12.34 after the company agreed To divest used motor oil collection and recycling assets for $140 million to Clean Harbors.</li>
	<li>Femasys Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEMY#NASDAQ">FEMY</a>) surged 18.9% to $9.70. The company last week priced its IPO at $13 per share.</li>
	<li>Verve Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERV#NASDAQ">VERV</a>) gained 18.6% to $64.36 after jumping over 20% on Tuesday.</li>
	<li>Xcel Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XELB#NASDAQ">XELB</a>) shares climbed 16.8% to $2.80 after gaining over 5% on Tuesday.</li>
	<li>Editas Medicine Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDIT#NASDAQ">EDIT</a>) climbed 16.6% to $53.74.</li>
	<li>Ocuphire Pharma Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCUP#NASDAQ">OCUP</a>) gained 16.6% to $5.54 after the company announced data from the VEGA-1 Phase 2 trial evaluating the efficacy and safety of Nyxol in combination with low-dose pilocarpine (LDP) in presbyopic subjects.</li>
	<li>Global Internet of People Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDH#NASDAQ">SDH</a>) gained 15.4% to $3.69 after climbing 11% on Tuesday.</li>
	<li>Dixie Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXYN#NASDAQ">DXYN</a>) climbed 13.1% to $2.98 after the company entered an agreement in principle to sell its commercial business to Mannington Mills.</li>
	<li>Bed Bath &amp; Beyond Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBBY#NASDAQ">BBBY</a>) gained 12.8% to $33.75 after the company reported better-than-expected Q1 results and raised FY21 guidance.</li>
	<li>Zhangmen Education Inc &ndash; ADR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZME#NYSE">ZME</a>) rose 12.4% to $15.36. The company, earlier during the month, priced its IPO at $11.50 per ADS.</li>
	<li>iPower Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPW#NASDAQ">IPW</a>) gained 12.2% to $8.37. The company last week reported a quarterly loss.</li>
	<li>AMMO, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POWW#NASDAQ">POWW</a>) climbed 11.5% to $9.80 after the company reported better-than-expected Q4 results.</li>
	<li>Evolving Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVOL#NASDAQ">EVOL</a>) gained 10.5% to $3.06 after gaining around 19% on Tuesday.</li>
	<li>Clear Secure Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YOU#NYSE">YOU</a>) gained 8.5% to $41.61 as the company priced its IPO at $31 a share.</li>
	<li>Kymera Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KYMR#NASDAQ">KYMR</a>) rose 8.2% to $46.17. Kymera Therapeutics recently commenced an underwritten public offering of 4 million shares of common stock.</li>
	<li>UTStarcom Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UTSI#NASDAQ">UTSI</a>) rose 7.2% to $1.64 after gaining 6% on Tuesday.</li>
	<li>Inpixon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INPX#NASDAQ">INPX</a>) rose 7.1% to $1.22. Inpixon was added to Russell Microcap Index, effective June 28.</li>
	<li>MingZhu Logistics Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YGMZ#NASDAQ">YGMZ</a>) rose 6.2% to $4.68 after the company announced it regained NASDAQ compliance.</li>
	<li>Exela Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XELA#NASDAQ">XELA</a>) gained 6% to $2.48. Exela Technologies shares jumped over 59% on Tuesday possibly on increased retail investor interest in the stock. Exela Technologies also announced the rollout of EON, its Robotic Process Automation platform for a large health insurance company.</li>
</ul>

<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>

<h3>Losers</h3>

<ul>
	<li>Altimmune, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALT#NASDAQ">ALT</a>) dropped 36.7% to $10.06 after the company provided an update on the Phase 1 AdCOVID clinical trial evaluating the safety and immunogenicity of the intranasally administered vaccine candidate, showing lower than expected immune responses for each of the immune parameters tested. Moving forward, Altimmune will focus its resources on the development of ALT-801 and HepTcell, its novel peptide-based therapeutics for obesity and liver diseases, the company said.</li>
	<li>Marin Software Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) shares dipped 36% to $11.12 amid profit taking after the stock surged Tuesday on Reddit-driven momentum. Marin Software provides a cloud-based digital advertising management solution for search, display, social and mobile advertising channels to improve financial performance, realize efficiencies and time savings and improve business decisions.</li>
	<li>BSQUARE Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSQR#NASDAQ">BSQR</a>) fell 35% to $5.26 after jumping over 206% on Tuesday.</li>
	<li>Kiromic BioPharma, Inc.. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRBP#NASDAQ">KRBP</a>) fell 27.9% to $4.79 after dropping 17% on Tuesday. The company recently announced it will be presenting at the 2021 Next-Gen Immuno Oncology Congress.</li>
	<li>electroCore, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ECOR#NASDAQ">ECOR</a>) fell 26.5% to $1.10 after the company priced an 18 million share common stock offering at $1 per share.</li>
	<li>Panbela Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBLA#NASDAQ">PBLA</a>) shares fell 25.4% to $2.85 after the company reported a $5 million bought deal offering of common stock.</li>
	<li>Qumu Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUMU#NASDAQ">QUMU</a>) shares fell 23.6% to $2.94 after the company reported weak preliminary revenue for the second quarter.</li>
	<li>CEL-SCI Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVM#NYSE">CVM</a>) dropped 22% to $10.00. CEL-SCI recently announced results from its Phase 3 study for its immunotherapy Multikine for advanced previously untreated squamous cell carcinoma of the head and neck (SCCHN).</li>
	<li>Riley Exploration Permian Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/REPX#NYSE">REPX</a>) fell 21.5% to $29.18 as the company priced 1,666,667 share common stock offering at $30 per share.</li>
	<li>Auddia Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) shares fell 20.7% to $5.56. Auddia shares gained 19% on Tuesday after the company announced the release and national launch of its flagship Auddia app ahead of schedule.</li>
	<li>Barnes &amp; Noble Education Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BNED#NYSE">BNED</a>) fell 18.2% to $7.10 after the company reported worse-than-expected Q4 results.</li>
	<li>OLB Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLB#NASDAQ">OLB</a>) dropped 17% to $5.37.</li>
	<li>Powerbridge Technologies Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBTS#NASDAQ">PBTS</a>) fell 16.2% to $2.40 after jumping 100% on Tuesday.</li>
	<li>Sphere 3D Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANY#NASDAQ">ANY</a>) dipped 15.8% to $2.60.</li>
	<li>Troika Media Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRKA#NASDAQ">TRKA</a>) fell 14.8% to $2.94 after jumping over 20% on Tuesday.</li>
	<li>Cerevel Therapeutics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERE#NASDAQ">CERE</a>) fell 14.7% to $25.33. Cerevel Therapeutics shares jumped 136% on Tuesday after the company announced topline results from Phase 1b trial of CVL-231, saying both doses of CVL-231 demonstrated a clinically meaningful and statistically significant improvement in PANSS Total score..</li>
	<li>Grid Dynamics Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDYN#NASDAQ">GDYN</a>) shares tumbled 13.9% to $15.10 after the company reported an offering of 10.1 million common shares.</li>
	<li>Universe Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) dropped 13.8% to $3.19. Universe Pharmaceuticals, last month, entered into Letter of Intent for strategic cooperation with Kitanihon Pharmaceutical.</li>
	<li>IKONICS Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IKNX#NASDAQ">IKNX</a>) dipped 10.6% to $18.95.</li>
	<li>Beachbody Company Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BODY#NYSE">BODY</a>) fell 8% to $10.27 after dropping 12% on Tuesday.</li>
	<li>Eagle Bulk Shipping Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGLE#NASDAQ">EGLE</a>) shares fell 7.2% to $47.55 after the company reported the pricing of an underwritten secondary public offering of 1,695,182 shares of common stock at $46.50 per share.</li>
	<li>MongoDB, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) shares fell 4.4% to $366.75 after the company priced an underwritten public offering of 2,500,000 shares of its Class A common stock at $365.00 per share.</li>
</ul>

51 Stocks Moving In Wednesday's Mid-Day Session

&nbsp;

<h3>Gainers</h3>

<ul>
	<li>Bridgeline Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLIN#NASDAQ">BLIN</a>) stock moved upwards by 114.6% to $7.28 during Wednesday&#39;s regular session. As of 12:30 EST, this security is trading at a volume of 90.5 million shares, making up 44391.81% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $46.9 million.</li>
	<li>Verb Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERB#NASDAQ">VERB</a>) stock moved upwards by 38.38% to $2.15. Trading volume for this security as of 12:30 EST is 72.3 million, which is 3859.36% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $135.9 million.</li>
	<li>Borqs Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRQS#NASDAQ">BRQS</a>) shares increased by 30.64% to $1.3. The current volume of 122.3 million shares is 4100.08% of Borqs Technologies&#39;s average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $158.4 million.</li>
	<li>My Size (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYSZ#NASDAQ">MYSZ</a>) stock increased by 17.36% to $1.69. My Size&#39;s stock is trading at a volume of 3.3 million shares as of 12:30 EST. This is 712.8% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $25.4 million.</li>
	<li>ServiceSource Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SREV#NASDAQ">SREV</a>) shares moved upwards by 10.6% to $1.46. Trading volume for this security as of 12:30 EST is 815.0K, which is 136.57% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $142.1 million.</li>
	<li>MMTEC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTC#NASDAQ">MTC</a>) shares moved upwards by 8.28% to $2.02. MMTEC&#39;s stock is trading at a volume of 4.9 million shares as of 12:30 EST. This is 2625.77% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $50.8 million.</li>
</ul>

&nbsp;

&nbsp;

<h3>Losers</h3>

&nbsp;

<ul>
	<li>Marin Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) stock fell 34.96% to $11.25 during Wednesday&#39;s regular session. The current volume of 40.2 million shares is 272.29% of Marin Software&#39;s average full-day volume over the last 100 days (last updated at 12:30 EST). The company&#39;s market cap stands at $123.4 million.</li>
	<li>BSQUARE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSQR#NASDAQ">BSQR</a>) shares fell 33.48% to $5.35. BSQUARE&#39;s stock is trading at a volume of 14.5 million shares as of 12:30 EST. This is 351.72% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $71.7 million.</li>
	<li>Qumu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUMU#NASDAQ">QUMU</a>) stock decreased by 25.01% to $2.89. Trading volume for this security as of 12:30 EST is 902.6K, which is 361.11% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $50.7 million.</li>
	<li>Auddia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) stock decreased by 18.9% to $5.69. As of 12:30 EST, this security is trading at a volume of 4.1 million shares, making up 184.13% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $64.1 million.</li>
	<li>Powerbridge Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBTS#NASDAQ">PBTS</a>) stock declined by 17.86% to $2.35. The current volume of 12.9 million shares is 792.22% of Powerbridge Technologies&#39;s average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $107.7 million.</li>
	<li>OLB Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLB#NASDAQ">OLB</a>) shares decreased by 15.26% to $5.5. OLB Gr&#39;s stock is trading at a volume of 272.5K shares as of 12:30 EST. This is 207.14% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $39.1 million.</li>
</ul>

&nbsp;

&nbsp;

12 Information Technology Stocks Moving In Wednesday's Intraday Session

<h3>Gainers</h3>

<ul>
	<li>Pop Culture Group Co., Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPOP#NASDAQ">CPOP</a>) shares jumped 405% to close at $30.30 on Wednesday after the company priced its IPO at $6 per share.</li>
	<li>Cuentas Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CUEN#NASDAQ">CUEN</a>) shares surged 123.7% to close at $6.22 on Wednesday. The stock spiked following a press release saying &quot;WaveMax to Implement the World&#39;s First Shared Wifi6 Network.&quot; Cuentas signed a contract to rollout SharedFi in 170 test locations in the New York City-Tristate area.</li>
	<li>Xometry, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XMTR#NASDAQ">XMTR</a>) gained 98.6% to settle at $87.39 after the company priced its IPO at $44 per share.</li>
	<li>Newegg Commerce, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEGG#NASDAQ">NEGG</a>) surged 78.3% to close at $19.38.</li>
	<li>Aerovate Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVTE#NASDAQ">AVTE</a>) climbed 63.1% to settle at $22.83 after the company priced its IPO at $14 per share.</li>
	<li>Dingdong (Cayman) Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDL#NYSE">DDL</a>) shares surged 62.8% to close at $38.30. Dingdong (Cayman) Limited priced its initial public offering of 4 million American depositary shares (ADS) at $23.5 per ADS. The total offering size is $95.7 million.</li>
	<li>CVRx, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVRX#NASDAQ">CVRX</a>) gained 55.6% to close at $28.00 as the company priced its IPO at $18 per share.</li>
	<li>Borqs Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRQS#NASDAQ">BRQS</a>) surged 45.7% to settle at $1.45 after gaining 11% on Tuesday. Borqs Technologies recently said it started delivery of cellular CTA-2045 products to SkyCentrics for use by utility companies for smart city deployment.</li>
	<li>1stdibs.Com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DIBS#NASDAQ">DIBS</a>) gained 40.9% to close at $34.81.</li>
	<li>Verb Technology Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERB#NASDAQ">VERB</a>) gained 32.3% to close at $2.05. Verb Technology shares gained over 17% on Tuesday after Ascendiant Capital initiated coverage on the stock with a Buy rating and a $4 price target.</li>
	<li>Clear Secure Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YOU#NYSE">YOU</a>) jumped 29% to close at $40.00 as the company priced its IPO at $31 a share.</li>
	<li>Vertex Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTNR#NASDAQ">VTNR</a>) shares climbed 28.8% to close at $13.23 after the company agreed To divest used motor oil collection and recycling assets for $140 million to Clean Harbors.</li>
	<li>Bridgeline Digital, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLIN#NASDAQ">BLIN</a>) rose 26.8% to close at $4.30 after jumping over 36% on Tuesday.</li>
	<li>AST SpaceMobile Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) climbed 26.7% to close at $12.94 after Deutsche Bank initiated coverage on the stock with a Buy rating and announced a $35 price target.</li>
	<li>Full Truck Alliance Co. Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YMM#NYSE">YMM</a>) gained 26.2% to close at $20.38 on continued volatility following last week&#39;s IPO.</li>
	<li>Xcel Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XELB#NASDAQ">XELB</a>) shares jumped 24.6% to close at $2.99 after gaining over 5% on Tuesday.</li>
	<li>Nam Tai Property Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTP#NYSE">NTP</a>) gained 24.4% to close at $27.71. Nam Tai Property&rsquo;s shareholder, IsZo Capital, late Sunday issued an update on Nam Tai&#39;s appeal of voided private placement.</li>
	<li>Aspen Aerogels, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASPN#NYSE">ASPN</a>) jumped 24.3% to close at $29.92 after the company late Tuesday announced a $75 million private placement by Koch Strategic Platforms.</li>
	<li>Editas Medicine Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDIT#NASDAQ">EDIT</a>) surged 22.9% to settle at $56.64.</li>
	<li>SentinelOne, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/S#NYSE">S</a>) gained 21.4% to close at $42.50 after pricing its IPO at $35 a share.</li>
	<li>Wireless Telecom Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WTT#NYSE">WTT</a>) surged 21.1% to close at $4.07.</li>
	<li>CNFinance Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNF#NYSE">CNF</a>) gained 20.8% to settle at $3.72.</li>
	<li>Uranium Royalty Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UROY#NASDAQ">UROY</a>) surged 20% to close at $3.00.</li>
	<li>Lands&#39; End, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LE#NASDAQ">LE</a>) gained 19.8% to close at $41.05.</li>
	<li>Moxian, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOXC#NASDAQ">MOXC</a>) surged 18.8% to settle at $22.29.</li>
	<li>CPS Technologies Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPSH#NASDAQ">CPSH</a>) gained 18.6% to close at $9.61.</li>
	<li>Global Internet of People Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDH#NASDAQ">SDH</a>) climbed 18.4% to close at $3.79 after climbing 11% on Tuesday.</li>
	<li>HUTCHMED (China) Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCM#NASDAQ">HCM</a>) climbed 18.2% to settle at $39.27. HUTCHMED and AstraZeneca&#39;s Orpathys recently received conditional approval in China.</li>
	<li>VistaGen Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTGN#NASDAQ">VTGN</a>) rose 17.5% to close at $3.15 after reporting a narrower FY21 loss.</li>
	<li>Vaccitech plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VACC#NASDAQ">VACC</a>) gained 17.1% to settle at $16.78.</li>
	<li>Beam Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAM#NASDAQ">BEAM</a>) surged 16.2% to close at $128.71 on continued strength following recent positive data announced by peer company Intellia.</li>
	<li>Peabody Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTU#NYSE">BTU</a>) surged 14.6% to close at $7.93.</li>
	<li>Integral Ad Science Holding Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAS#NASDAQ">IAS</a>) jumped 14.3% to settle at $20.58 after the company priced its IPO at $18 a share.</li>
	<li>InfuSystem Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INFU#NYSE">INFU</a>) surged 14.2% to close at $20.79 after the company announced a $20 million share buyback plan.</li>
	<li>Kymera Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KYMR#NASDAQ">KYMR</a>) gained 13.7% to close at $48.50. Kymera Therapeutics recently commenced an underwritten public offering of 4 million shares of common stock.</li>
	<li>Dixie Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXYN#NASDAQ">DXYN</a>) gained 11.4% to close at $2.93 after the company entered an agreement in principle to sell its commercial business to Mannington Mills.</li>
	<li>AMMO, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POWW#NASDAQ">POWW</a>) gained 11.4% to close at $9.79 after the company reported better-than-expected Q4 results.</li>
	<li>Bed Bath &amp; Beyond Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBBY#NASDAQ">BBBY</a>) climbed 11.3% to close at $33.29 after the company reported better-than-expected Q1 results and raised FY21 guidance.</li>
	<li>Ocuphire Pharma Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCUP#NASDAQ">OCUP</a>) rose 11.2% to close at $5.28 after the company announced data from the VEGA-1 Phase 2 trial evaluating the efficacy and safety of Nyxol in combination with low-dose pilocarpine (LDP) in presbyopic subjects.</li>
	<li>Verve Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERV#NASDAQ">VERV</a>) rose 11.1% to close at $60.25 after jumping over 20% on Tuesday.</li>
	<li>Weidai Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WEI#NYSE">WEI</a>) shares jumped 10.5% to close at $1.79 after gaining 50% on Tuesday.</li>
	<li>MingZhu Logistics Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YGMZ#NASDAQ">YGMZ</a>) rose 7.7% to close at $4.75 after the company announced it regained NASDAQ compliance.</li>
	<li>Intellia Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTLA#NASDAQ">NTLA</a>) rose 6.8% to close at $161.91 after the company priced a previously announced public offering at $145 per share, representing a discount of 4.4% from the last close price of $151.6 on Tuesday.</li>
</ul>

&nbsp;

&nbsp;

<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>

<h3>Losers</h3>

<ul>
	<li>BSQUARE Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSQR#NASDAQ">BSQR</a>) dropped 40.7% to close at $4.77 after jumping over 206% on Tuesday.</li>
	<li>Altimmune, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALT#NASDAQ">ALT</a>) shares declined 38.1% to close at $9.85 on Wednesday after the company provided an update on the Phase 1 AdCOVID clinical trial evaluating the safety and immunogenicity of the intranasally administered vaccine candidate, showing lower than expected immune responses for each of the immune parameters tested. Moving forward, Altimmune will focus its resources on the development of ALT-801 and HepTcell, its novel peptide-based therapeutics for obesity and liver diseases, the company said.</li>
	<li>Marin Software Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) shares fell 38% to settle at $10.73 amid profit taking after the stock surged Tuesday on Reddit-driven momentum. Marin Software provides a cloud-based digital advertising management solution for search, display, social and mobile advertising channels to improve financial performance, realize efficiencies and time savings and improve business decisions.</li>
	<li>CEL-SCI Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVM#NYSE">CVM</a>) dipped 32.4% to close at $8.68. CEL-SCI recently announced results from its Phase 3 study for its immunotherapy Multikine for advanced previously untreated squamous cell carcinoma of the head and neck (SCCHN).</li>
	<li>Kiromic BioPharma, Inc.. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRBP#NASDAQ">KRBP</a>) fell 27.6% to settle at $4.81 after dropping 17% on Tuesday. The company recently announced it will be presenting at the 2021 Next-Gen Immuno Oncology Congress.</li>
	<li>Panbela Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBLA#NASDAQ">PBLA</a>) shares dipped 25.9% to close at $2.83 after the company reported a $5 million bought deal offering of common stock.</li>
	<li>Qumu Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUMU#NASDAQ">QUMU</a>) shares tumbled 25.2% to close at $2.88 after the company reported weak preliminary revenue for the second quarter.</li>
	<li>Powerbridge Technologies Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBTS#NASDAQ">PBTS</a>) fell 24.5% to close at $2.16 after jumping 100% on Tuesday.</li>
	<li>Riley Exploration Permian Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/REPX#NYSE">REPX</a>) dropped 22.1% to settle at $28.98 as the company priced 1,666,667 share common stock offering at $30 per share.</li>
	<li>Alzamend Neuro, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALZN#NASDAQ">ALZN</a>) declined 21% to close at $8.74.</li>
	<li>electroCore, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ECOR#NASDAQ">ECOR</a>) fell 20.1% to close at $1.19 after the company priced an 18 million share common stock offering at $1 per share.</li>
	<li>Auddia Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) shares fell 19.5% to close at $5.64. Auddia shares gained 19% on Tuesday after the company announced the release and national launch of its flagship Auddia app ahead of schedule.</li>
	<li>Troika Media Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRKA#NASDAQ">TRKA</a>) fell 17.7% to close at $2.84 after jumping over 20% on Tuesday.</li>
	<li>Barnes &amp; Noble Education Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BNED#NYSE">BNED</a>) declined 16.8% to close at $7.21 after the company reported worse-than-expected Q4 results.</li>
	<li>OLB Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLB#NASDAQ">OLB</a>) dropped 15.9% to close at $5.46.</li>
	<li>Sphere 3D Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANY#NASDAQ">ANY</a>) dipped 15.5% to close at $2.61.</li>
	<li>SELLAS Life Sciences Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLS#NASDAQ">SLS</a>) fell 15.1% to close at $11.10 as the company announced updated data and initial immunobiological data from its Phase 1/2 evaluating its lead asset, galinpepimut-S (GPS), in ovarian cancer.</li>
	<li>Grom Social Enterprises, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GROM#NASDAQ">GROM</a>) dipped 14.6% to settle at $3.50.</li>
	<li>Grid Dynamics Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDYN#NASDAQ">GDYN</a>) shares tumbled 14.4% to close at $15.03 after the company reported an offering of 10.1 million common shares.</li>
	<li>Universe Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) dropped 14.3% to close at $3.17. Universe Pharmaceuticals, last month, entered into Letter of Intent for strategic cooperation with Kitanihon Pharmaceutical.</li>
	<li>Cerevel Therapeutics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERE#NASDAQ">CERE</a>) fell 13.7% to settle at $25.62. Cerevel Therapeutics shares jumped 136% on Tuesday after the company announced topline results from Phase 1b trial of CVL-231, saying both doses of CVL-231 demonstrated a clinically meaningful and statistically significant improvement in PANSS Total score.</li>
	<li>Bon Natural Life Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BON#NASDAQ">BON</a>) dipped 13.3% to close at $6.85. The company recently priced its IPO at $5 per share.</li>
	<li>iSpecimen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPC#NASDAQ">ISPC</a>) dropped 13.2% to settle at $7.22. The company recently priced its IPO at $8 per share.</li>
	<li>Evolving Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVOL#NASDAQ">EVOL</a>) fell 11.9% to close at $2.44 after gaining around 19% on Tuesday.</li>
	<li>Tempest Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPST#NASDAQ">TPST</a>) declined 10.1% to close at $11.18.</li>
	<li>IKONICS Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IKNX#NASDAQ">IKNX</a>) dipped 8.9% to close at $19.31.</li>
	<li>Eagle Bulk Shipping Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGLE#NASDAQ">EGLE</a>) shares fell 7.6% to close at $47.32 after the company reported the pricing of an underwritten secondary public offering of 1,695,182 shares of common stock at $46.50 per share.</li>
	<li>Beachbody Company Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BODY#NYSE">BODY</a>) fell 7.1% to close at $10.40 after dropping 12% on Tuesday.</li>
	<li>MongoDB, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) shares fell 5.8% to close at $361.52 after the company priced an underwritten public offering of 2,500,000 shares of its Class A common stock at $365.00 per share.</li>
</ul>

72 Biggest Movers From Yesterday

<h3>Gainers</h3>
<ul>
<li>Auddia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) stock rose 4.62% to $7.69 during Thursday's after-market session. This security traded at a volume of 1.0 million shares come close, making up 45.0% of its average volume over the last 100 days. The market value of their outstanding shares is at $86.8 million. </li>
<li>Neonode (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEON#NASDAQ">NEON</a>) shares rose 3.96% to $6.55. Trading volume for this security closed at 354, accounting for 0.95% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $75.3 million. </li>
<li>Sonim Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONM#NASDAQ">SONM</a>) stock rose 2.61% to $0.56. Today's trading volume for this security ended up closing at 4.7K shares, which is 0.17 percent of its average volume over the last 100 days. The company's market cap stands at $37.2 million. </li>
<li>McAfee (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCFE#NASDAQ">MCFE</a>) shares rose 2.22% to $28.99. Today's trading volume for this security ended up closing at 254.2K shares, which is 24.48 percent of its average volume over the last 100 days. The company's market cap stands at $12.4 billion. </li>
<li>DoubleVerify Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DV#NYSE">DV</a>) shares moved upwards by 2.12% to $42.34. Today's trading volume for this security ended up closing at 8.3K shares, which is 1.22 percent of its average volume over the last 100 days. The company's market cap stands at $6.6 billion. </li>
<li>Infobird Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IFBD#NASDAQ">IFBD</a>) stock increased by 1.19% to $4.23. Infobird Co's trading volume hit 28.8K shares by close, accounting for 1.17% of its average volume over the last 100 days. The market value of their outstanding shares is at $106.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Marin Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) shares fell 6.7% to $14.07 during Thursday's after-market session. Today's trading volume for this security ended up closing at 1.3 million shares, which is 8.58 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $154.3 million. </li>
<li>Bridgeline Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLIN#NASDAQ">BLIN</a>) shares declined by 5.22% to $5.45. Trading volume for this security closed at 716.3K, accounting for 32.06% of its average full-day volume over the last 100 days. The company's market cap stands at $35.1 million. </li>
<li>My Size (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYSZ#NASDAQ">MYSZ</a>) shares decreased by 2.64% to $1.48. This security traded at a volume of 731 shares come close, making up 0.13% of its average volume over the last 100 days. The market value of their outstanding shares is at $22.2 million. </li>
<li>Exela Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XELA#NASDAQ">XELA</a>) stock fell 2.36% to $2.07. Trading volume for this security closed at 767.4K, accounting for 4.95% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $122.5 million. </li>
<li>Verb Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERB#NASDAQ">VERB</a>) shares decreased by 2.1% to $1.87. Verb Tech's trading volume hit 39.3K shares by close, accounting for 1.2% of its average volume over the last 100 days. The market value of their outstanding shares is at $118.4 million. </li>
<li>Color Star Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCW#NASDAQ">CSCW</a>) shares decreased by 1.89% to $1.04. Today's trading volume for this security ended up closing at 10.0K shares, which is 0.11 percent of its average volume over the last 100 days. The company's market cap stands at $93.9 million. </li>
</ul>

12 Information Technology Stocks Moving In Thursday's After-Market Session

<h3>Gainers</h3>

<ul>
	<li>The Glimpse Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRAR#NASDAQ">VRAR</a>) shares jumped 152.3% to settle at $17.66 on Thursday after the company priced its IPO at $7 per share.</li>
	<li>Pop Culture Group Co., Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPOP#NASDAQ">CPOP</a>) shares climbed 97.7% to close at $59.90 on Thursday. Pop Culture Group shares jumped 405% on Wednesday after the company priced its IPO at $6 per share.</li>
	<li>Alterity Therapeutics Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATHE#NASDAQ">ATHE</a>) shares gained 64.6% to settle at $2.14. Alterity Therapeutics recently said it received EU regulatory guidance for ATH434 Phase 2 clinical trial.</li>
	<li>TRxADE HEALTH, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDS#NASDAQ">MEDS</a>) gained 62.6% to close at $7.17. TRxADE HEALTH&rsquo;s subsidiary Bonum Health signed a Telemedicine Service Distribution Deal with Big Y Pharmacy and Wellness Centers.</li>
	<li>Marin Software Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) shares jumped 40.5% to close at $7.17 after dropping 38% on Tuesday. Marin Software provides a cloud-based digital advertising management solution for search, display, social and mobile advertising channels to improve financial performance, realize efficiencies and time savings and improve business decisions.</li>
	<li>Eco Wave Power Global AB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WAVE#NASDAQ">WAVE</a>) gained 35.6% to close at $10.85 as the company priced its IPO at $8/ADS.</li>
	<li>Bridgeline Digital Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLIN#NASDAQ">BLIN</a>) gained 33.7% to settle at $5.75 after climbing over 26% on Wednesday.</li>
	<li>Auddia Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) gained 30.3% to close at $7.35. Auddia recently announced the release and national launch of its flagship Auddia app ahead of schedule.</li>
	<li>Birks Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BGI#NYSE">BGI</a>) shares gained 29.4% to close at $3.04. Birks Group, last month, reported FY21 sales of C$143.1 million, down 15.5% year-on-year.</li>
	<li>Pulse Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLSE#NASDAQ">PLSE</a>) climbed 27% to settle at $20.82. Pulse Biosciences is a bioelectric medicine firm, working on innovative health products across a wide range of conditions.</li>
	<li>Acumen Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABOS#NASDAQ">ABOS</a>) gained 25.6% to close at $20.10 as the company priced its IPO at $16 per share.</li>
	<li>Grid Dynamics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDYN#NASDAQ">GDYN</a>) rose 25.1% to close at $18.80 after the company priced 10.1 million shares at $15.03 per share in a follow-on secondary public offering.</li>
	<li>Wunong Net Technology Co Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WNW#NASDAQ">WNW</a>) climbed 24.2% to close at $8.20 after declining around 5% on Wednesday.</li>
	<li>Krispy Kreme, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DNUT#NASDAQ">DNUT</a>) gained 23.5% to settle at $21.00 as the company priced its IPO at $17 per share.</li>
	<li>U.S. Silica Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLCA#NYSE">SLCA</a>) climbed 20.6% to close at $6.82. US Silica&rsquo;s 8-K showed the company entered into a deal to settle customer dispute related to fees for minimum purchase commitments from 2014-2020.</li>
	<li>Clear Secure, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YOU#NYSE">YOU</a>) gained 19.8% to close at $47.92 on continued volatility following Wednesday&#39;s IPO.</li>
	<li>IKONICS Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IKNX#NASDAQ">IKNX</a>) rose 18.1% to settle at $22.80.</li>
	<li>SGOCO Group, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGOC#NASDAQ">SGOC</a>) surged 18.1% to close at $2.94.</li>
	<li>The Dixie Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXYN#NASDAQ">DXYN</a>) jumped 17.7% to close at $3.45. Dixie Group recently agreed to sell its commercial business to Mannington Mills Inc.</li>
	<li>Vincerx Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VINC#NASDAQ">VINC</a>) rose 17.7% to settle at $15.29 after the company announced the purchase of 27.8K shares by the CEO and a director. The stock has also been purchased in large amounts by other insiders.</li>
	<li>Earthstone Energy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESTE#NYSE">ESTE</a>) surged 17.5% to close at $13.01.</li>
	<li>Spero Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPRO#NASDAQ">SPRO</a>) gained 17.4% to settle at $16.39 after the company reported a $40 Million equity investment from Pfizer Inc. and licensing agreement for SPR206.</li>
	<li>scPharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCPH#NASDAQ">SCPH</a>) surged 17% to close at $7.15 after the company announced it has received the required minutes from its Type C meeting with the FDA for resubmission of the FUROSCIX new drug application.</li>
	<li>Didi Global Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIDI#NYSE">DIDI</a>) climbed 16% to close at $16.40. The company on Wednesday priced its IPO at $14 a share.</li>
	<li>Aspen Aerogels, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASPN#NYSE">ASPN</a>) surged 15.8% to settle at $34.66 following multiple bullish ratings on the stock. The company also announced a $75 million private placement.</li>
	<li>Kymera Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KYMR#NASDAQ">KYMR</a>) rose 15.6% to close at $56.07. The company priced its 4.755 million share offering at $47 per share, totalling $223 million.</li>
	<li>Torrid Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CURV#NYSE">CURV</a>) surged 15% to close at $24.15 after pricing its IPO at $21 per share.</li>
	<li>Abraxas Petroleum Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXAS#NASDAQ">AXAS</a>) rose 13.6% to close at $3.67.</li>
	<li>ON24, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONTF#NYSE">ONTF</a>) surged 12% to settle at $39.74.</li>
	<li>FAST Acquisition Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FST#NYSE">FST</a>) gained 11.4% to close at $13.15 following late Wednesday Bloomberg report &#39;Billionaire Fertitta to Add Restaurants, Aquariums to SPAC Deal.&#39;</li>
	<li>Franklin Covey Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FC#NYSE">FC</a>) surged 11.3% to close at $36.00 after the company reported better-than-expected Q3 sales results and raised its FY21 Adj. EBITDA guidance.</li>
	<li>US Well Services Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USWS#NASDAQ">USWS</a>) jumped 10.9% to close at $1.12 after the company announced the commitment to purchase 120 electric motors totaling 360,000 HHP.</li>
	<li>Hut 8 Mining Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUT#NYSE">HUT</a>) rose 7.7% to close at $4.74. Hut 8 Mining recently announced the purchase of 12,000 new MicroBT miners for deployment by the end of Q4.</li>
	<li>Express, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXPR#NYSE">EXPR</a>) gained 5.1% to settle at $6.82.</li>
</ul>

&nbsp;

 
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>

<h3>Losers</h3>

<ul>
	<li>Xometry, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XMTR#NASDAQ">XMTR</a>) fell 25.4% to close at $65.23. The company priced its IPO at $44 a share.</li>
	<li>Citius Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTXR#NASDAQ">CTXR</a>) shares fell 25.3% to close at $2.60 on Thursday after the company announced recommendation by Independent Data Monitoring Committee to continue Mino-Lok Phase 3 trial as planned.</li>
	<li>Borqs Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRQS#NASDAQ">BRQS</a>) fell 22.1% to close at $1.13 on Thursday after jumping over 45% on Wednesday.</li>
	<li>1stdibs.Com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DIBS#NASDAQ">DIBS</a>) fell 22.1% to close at $27.11 after climbing over 40% on Wednesday.</li>
	<li>Aligos Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGS#NASDAQ">ALGS</a>) fell 17.3% to close at $16.86. ligos Therapeutics priced a previously announced underwritten public offering of 4.4 million shares at $19 per share, representing a discount of 7% from the last close price of $20.3 on Wednesday.</li>
	<li>SELLAS Life Sciences Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLS#NASDAQ">SLS</a>) dropped 16% to close at $9.33. Sellas Life Sciences Group recently announced updated data and initial immunobiological data from its Phase 1/2 evaluating its lead asset, galinpepimut-S (GPS), in ovarian cancer.</li>
	<li>Nam Tai Property Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTP#NYSE">NTP</a>) fell 15.3% to close at $23.48.</li>
	<li>Micro Focus International plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MFGP#NYSE">MFGP</a>) fell 15.1% to settle at $6.39.</li>
	<li>Dingdong (Cayman) Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDL#NYSE">DDL</a>) fell 15% to close at $32.57. Dingdong (Cayman) Limited recently priced its initial public offering of 4 million American depositary shares (ADS) at $23.5 per ADS. The total offering size is $95.7 million.</li>
	<li>Aerovate Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVTE#NASDAQ">AVTE</a>) fell 15% to close at $19.41. The company priced 8.68 million shares at $14, the midpoint of a $13 to $15 range.</li>
	<li>NovoCure Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVCR#NASDAQ">NVCR</a>) dipped 14.5% to close at $189.72 after the company announced final results from its Phase 2 pilot HEPANOVA trial in liver cancer.</li>
	<li>X Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYF#NYSE">XYF</a>) fell 13.8% to close at $11.73, selling off following the stock&#39;s recent surge.</li>
	<li>Codex DNA, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DNAY#NASDAQ">DNAY</a>) dipped 13% to close at $19.15. The company recently priced its IPO at $16 per share.</li>
	<li>E-Home Household Service Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EJH#NASDAQ">EJH</a>) fell 12.7% to close at $25.33.</li>
	<li>Global Internet of People, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDH#NASDAQ">SDH</a>) fell 12.6% to close at $3.31.</li>
	<li>Alzamend Neuro, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALZN#NASDAQ">ALZN</a>) dipped 12.1% to settle at $7.68. Ault Global Holdings, a diversified holding company, has announced that Alzamend Neuro has submitted an investigational new drug application to the FDA for a Phase 1 study of AL001.</li>
	<li>Verve Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERV#NASDAQ">VERV</a>) fell 11.8% to close at $53.14 on continued post-IPO volatility.</li>
	<li>SunLink Health Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSY#NYSE">SSY</a>) fell 11.7% to settle at $3.02.</li>
	<li>Onion Global Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OG#NYSE">OG</a>) dipped 11.1% to close at $3.85.</li>
	<li>Newegg Commerce Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEGG#NASDAQ">NEGG</a>) shares fell 9.9% to settle at $17.46 after jumping 78% on Wednesday.</li>
	<li>Houston American Energy Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUSA#NASDAQ">HUSA</a>) fell 9.7% to close at $2.24 after jumping over 48% on Wednesday.</li>
	<li>Weidai Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WEI#NYSE">WEI</a>) fell 8.9% to close at $1.63 after gaining 14% on Wednesday.</li>
	<li>CureVac BV (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVAC#NASDAQ">CVAC</a>) fell 7.7% to close at $67.85 after the company released final data from its Phase 2b/3 trial of its first-generation COVID-19 vaccine candidate.</li>
	<li>Verb Technology Company Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERB#NASDAQ">VERB</a>) fell 6.8% to settle at $1.91 after surging 32% on Wednesday. Ascendiant Capital recently initiated coverage on the stock with a Buy rating and a $4 price target.</li>
</ul>

<h3>Gainers</h3>
<ul>
<li>Bridgeline Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLIN#NASDAQ">BLIN</a>) stock moved upwards by 13.6% to $10.19 during Friday's after-market session. At the close, Bridgeline Digital's trading volume reached 5.5 million shares. This is 158.18% of its average volume over the last 100 days. The company's market cap stands at $65.7 million. </li>
<li>Nxt-ID (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXTD#NASDAQ">NXTD</a>) shares rose 2.79% to $0.91. At the close, Nxt-ID's trading volume reached 32.7K shares. This is 1.17% of its average volume over the last 100 days. The market value of their outstanding shares is at $48.2 million. </li>
<li>Powerbridge Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBTS#NASDAQ">PBTS</a>) stock increased by 2.77% to $1.85. Today's trading volume for this security ended up closing at 32.2K shares, which is 1.6 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $84.8 million. </li>
<li>Kopin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KOPN#NASDAQ">KOPN</a>) shares rose 1.8% to $7.91. At the close, Kopin's trading volume reached 84.4K shares. This is 2.47% of its average volume over the last 100 days. The company's market cap stands at $722.0 million. </li>
<li>Paya Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYA#NASDAQ">PAYA</a>) stock increased by 1.73% to $11.7. Paya Holdings's trading volume hit 8.0K shares by close, accounting for 0.58% of its average volume over the last 100 days. The company's market cap stands at $1.4 billion. </li>
<li>Summit Wireless (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WISA#NASDAQ">WISA</a>) stock moved upwards by 1.52% to $4.0. At the close, Summit Wireless's trading volume reached 3.8K shares. This is 0.41% of its average volume over the last 100 days. The market value of their outstanding shares is at $45.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>BSQUARE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSQR#NASDAQ">BSQR</a>) shares fell 2.77% to $3.87 during Friday's after-market session. Today's trading volume for this security ended up closing at 149.1K shares, which is 3.01 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $51.8 million. </li>
<li>My Size (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYSZ#NASDAQ">MYSZ</a>) shares decreased by 2.64% to $1.48. Today's trading volume for this security ended up closing at 263 shares, which is 0.05 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $22.2 million. </li>
<li>Marin Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) shares decreased by 1.88% to $19.91. Today's trading volume for this security ended up closing at 662.0K shares, which is 3.6 percent of its average volume over the last 100 days. The company's market cap stands at $218.3 million. </li>
<li>Support.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPRT#NASDAQ">SPRT</a>) stock fell 1.83% to $4.3. Support.com's trading volume hit 5.6K shares by close, accounting for 0.43% of its average volume over the last 100 days. The market value of their outstanding shares is at $103.6 million. </li>
<li>Auddia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) stock fell 1.62% to $7.3. At the close, Auddia's trading volume reached 40.3K shares. This is 1.6% of its average volume over the last 100 days. The company's market cap stands at $82.4 million. </li>
<li>Red Cat Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCAT#NASDAQ">RCAT</a>) stock fell 1.58% to $2.5. Red Cat Holdings's trading volume hit 2.8K shares by close, accounting for 0.68% of its average volume over the last 100 days. The company's market cap stands at $84.6 million. </li>
</ul>

12 Information Technology Stocks Moving In Friday's After-Market Session

<h3>Gainers</h3>

<ul>
	<li>Odonate Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODT#NASDAQ">ODT</a>) shares rose 38.3% to $4.80 in pre-market trading following 13G from Ikarian Capital showing a 5.2% stake in the company.</li>
	<li>BSQUARE Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSQR#NASDAQ">BSQR</a>) shares rose 36.2% to $5.42 in pre-market trading after dropping around 10% on Friday.</li>
	<li>Sequential Brands Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SQBG#NASDAQ">SQBG</a>) shares rose 33.7% to $20.99 in pre-market trading after jumping 89% on Friday.</li>
	<li>Marin Software Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) rose 22% to $24.75 in pre-market trading after climbing around 35% on Friday amid continued extreme volatility and volume in the stock from investors following the company&#39;s Instacart Ads integration announcement.</li>
	<li>Bridgeline Digital, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLIN#NASDAQ">BLIN</a>) shares rose 21.6% to $10.91 in pre-market trading after jumping 56% on Friday. Bridgeline Digital, last week, announced its partner network won more than 20 site search licenses this quarter for Celebros and HawkSearch, its most recent acquisition.</li>
	<li>Ocugen, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCGN#NASDAQ">OCGN</a>) shares rose 18.4% to $8.63 in pre-market trading after declining 7% on Friday.</li>
	<li>Taiwan Liposome Company, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLC#NASDAQ">TLC</a>) rose 11.7% to $6.40 in pre-market trading. TLC recently announced details of stock swap transactions.</li>
	<li>Auddia Inc.(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) shares rose 9.2% to $8.10 in pre-market trading. Auddia recently announced the release and national launch of its flagship Auddia app ahead of schedule.</li>
	<li>Immutep Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMMP#NASDAQ">IMMP</a>) rose 9% to $4.25 in pre-market trading after the company reported the FDA and IRB approval in the US for Phase IIb TACTI-003 trial in Head and Neck Squamous Cell Carcinoma.</li>
	<li>IVERIC bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISEE#NASDAQ">ISEE</a>) rose 8.7% to $8.63 in pre-market trading after the company said it received FDA agreement under special protocol assessment for GATHER2 Phase 3 clinical trial of zimura in geographic atrophy secondary to age-related macular degeneration.</li>
	<li>MediciNova, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNOV#NASDAQ">MNOV</a>) rose 8.3% to $4.45 in pre-market trading after the company received notice of allowance for new patent covering MN-166 for the treatment of ophthalmic disease.</li>
	<li>Eco Wave Power Global AB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WAVE#NASDAQ">WAVE</a>) rose 8.1% to $20.30 in pre-market trading after jumping 73% on Friday. The company, last week, priced its IPO at $8 per ADS.</li>
	<li>Vermilion Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VET#NYSE">VET</a>) rose 7% to $9.41 in pre-market trading.</li>
	<li>Vislink Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VISL#NASDAQ">VISL</a>) rose 6.7% to $3.20 in pre-market trading. Vislink joined Russell Microcap Index effective June 28.</li>
	<li>Camber Energy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CEI#NYSE">CEI</a>) rose 5.5% to $0.71 in pre-market trading after declining over 12% on Friday.</li>
	<li>Himax Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIMX#NASDAQ">HIMX</a>) rose 5.4% to $15.54 in pre-market trading after declining over 7% on Friday.</li>
	<li>AngloGold Ashanti Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AU#NYSE">AU</a>) rose 5.4% to $20.10 in pre-market trading. AngloGold Ashanti named Alberto Calderon as its new chief executive officer.</li>
	<li>Cano Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CANO#NYSE">CANO</a>) rose 4% to $12.49 in pre-market trading as the company said it has acquired Doctor&#39;s Medical Center for $300 million.</li>
</ul>

 
 
Find out what&#39;s going on in today&#39;s market and bring any questions you have to <a href="http://premarket.benzinga.com/pre-market-show/">Benzinga&#39;s PreMarket Prep</a>.

<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>

<h3>Losers</h3>

<ul>
	<li>Ashford Hospitality Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AHT#NYSE">AHT</a>) fell 25.2% to $2.96 in pre-market trading. Ashford Trust reported a 1-for-10 reverse stock split extending management&#39;s commitment to making AHT shareholder friendly. The company said it entered into common stock purchase agreement with B. Riley Principal Capital.</li>
	<li>Full Truck Alliance Co. Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YMM#NYSE">YMM</a>) shares fell 15.9% to $16.00 in pre-market trading The company, last month, priced its IPO at $19 per ADS.</li>
	<li>Pop Culture Group Co., Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPOP#NASDAQ">CPOP</a>) fell 12.4% to $46.78 in pre-market trading after dropping over 10% on Friday. Pop Culture Group recently priced its IPO at $6 per share.</li>
	<li>Sequential Brands Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SQBG#NASDAQ">SQBG</a>) fell 10.3% to $14.09 in pre-market trading after jumping 89% on Friday.</li>
	<li>Kanzhun Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZ#NASDAQ">BZ</a>) fell 10.2% to $32.60 in pre-market trading.</li>
	<li>Nortech Systems Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSYS#NASDAQ">NSYS</a>) fell 8.4% to $9.00 in pre-market trading after climbing around 27% on Friday.</li>
	<li>Tata Motors Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTM#NYSE">TTM</a>) shares fell 8.3% to $21.14 in pre-market trading.</li>
	<li>Staffing 360 Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STAF#NASDAQ">STAF</a>) shares fell 8.1% to $4.59 in pre-market trading after jumping around 35% on Friday.</li>
	<li>Alterity Therapeutics Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATHE#NASDAQ">ATHE</a>) fell 8% to $1.61 in pre-market trading. Alterity Therapeutics recently announced it was granted a new US patent targeting major neurodegenerative diseases including Alzheimer&#39;s and Parkinson&#39;s..</li>
	<li>Provention Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRVB#NASDAQ">PRVB</a>) fell 7.2% to $7.70 in pre-market trading.</li>
</ul>

28 Stocks Moving in Tuesday's Pre-Market Session

<ul>
	<li>AI platform developer&nbsp;Auddia Inc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>)&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/pressreleases/21/07/ac21852387/auddia-inc-announces-radioalabama-as-the-third-broadcast-radio-group-added-to-the-auddia-app" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">named RadioAlabama as the</a>&nbsp;third radio station group on the Auddia platform.</li>
	<li>It expands Auddia&#39;s launch, marking the first-time radio broadcasters&#39; promotion of a subscription-based commercial-free premium listening experience.</li>
	<li>Auddia forged its&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/pressreleases/21/03/ac20230644/auddia-inc-announces-its-first-broadcast-radio-partnership-as-it-launches-with-lakes-media-llc" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">first broadcast radio partnership</a>&nbsp;with Lakes Media LLC in March.</li>
	<li>Amaturo Sonoma Media LLC (ASMG or Sonoma Media) was the&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/pressreleases/21/04/ac20832395/auddia-inc-announces-its-second-broadcast-radio-partnership-as-it-launches-with-amaturo-sonoma-me" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">second broadcast radio partner</a>&nbsp;as announced in April.</li>
	<li>Price action:&nbsp;AUUD shares traded higher by 1.48% at $7.53 on the last check Tuesday.</li>
</ul>

Tech

Media

Auddia Names RadioAlabama As Third Broadcast Radio Partner

<h3>Gainers</h3>

<ul>
	<li>Orbsat Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSAT#NASDAQ">OSAT</a>) shares jumped 74% to $9.47.</li>
	<li>BSQUARE Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSQR#NASDAQ">BSQR</a>) shares jumped 48.2% to $5.90 after dropping around 10% on Friday.</li>
	<li>Bridgeline Digital, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLIN#NASDAQ">BLIN</a>) shares jumped 41.3% to $12.67 after jumping 56% on Friday. Bridgeline Digital, last week, announced its partner network won more than 20 site search licenses this quarter for Celebros and HawkSearch, its most recent acquisition.</li>
	<li>PFSweb, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFSW#NASDAQ">PFSW</a>) gained 39.8% to $10.59 after the company agreed to sell LiveArea business to Merkle for $250 million.</li>
	<li>Sequential Brands Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SQBG#NASDAQ">SQBG</a>) shares climbed 37% to $21.50 after jumping 89% on Friday.</li>
	<li>Advaxis, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADXS#NASDAQ">ADXS</a>) shares climbed 27.4% to $0.6011 after the company announced it entered into a definitive merger agreement with Biosight and Biosight shareholders will become majority shareholders in the combined company.</li>
	<li>Marin Software Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) climbed 25% to $25.34 after climbing around 35% on Friday amid continued extreme volatility and volume in the stock from investors following the company&#39;s Instacart Ads integration announcement.</li>
	<li>Clearside Biomedical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSD#NASDAQ">CLSD</a>) gained 25% to $6.72.</li>
	<li>Larimar Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRMR#NASDAQ">LRMR</a>) surged 20.5% to $11.92.</li>
	<li>Atossa Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATOS#NASDAQ">ATOS</a>) gained 15.3% to $6.19 after dropping 16% on Friday.</li>
	<li>Taiwan Liposome Company, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLC#NASDAQ">TLC</a>) jumped 15.2% to $6.60. TLC recently announced details of stock swap transactions.</li>
	<li>Axcella Health Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXLA#NASDAQ">AXLA</a>) surged 14.6% to $4.55 after HC Wainwright &amp; Co initiated coverage on the stock with a Buy rating and a $14 price target.</li>
	<li>Bon Natural Life Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BON#NASDAQ">BON</a>) climbed 14.4% to $9.21 after the company received the certificate of a land use right for the future site of its third production facility in the city of Yumen.</li>
	<li>Cleveland BioLabs, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBLI#NASDAQ">CBLI</a>) jumped 13.7% to $6.61. The company today conducted a merger vote.</li>
	<li>Tempest Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPST#NASDAQ">TPST</a>) gained 13% to $12.68. Piper Sandler initiated coverage on Tempest Therapeutics with an Overweight rating and announced a price target of $23.</li>
	<li>Xcel Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XELB#NASDAQ">XELB</a>) gained 13% to $3.0853.</li>
	<li>Alector, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALEC#NASDAQ">ALEC</a>) gained 11.7% to $39.39. Alector and GlaxoSmithKline recently announced a global collaboration for the development and commercialization of two monoclonal antibodies designed to elevate progranulin (PGRN) levels.</li>
	<li>Data Storage Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTST#NASDAQ">DTST</a>) climbed 10% to $6.49.</li>
	<li>Odonate Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODT#NASDAQ">ODT</a>) shares gained 8.4% to $3.76 following 13G from Ikarian Capital showing a 5.2% stake in the company.</li>
	<li>Ocugen, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCGN#NASDAQ">OCGN</a>) shares gained 7.4% to $7.84. Armed with new data from its development partner Bharat Biotech, Ocugen plans to press ahead with plans to file for approval of their COVID-19 vaccine, Covaxin, in the U.S. and Canada.</li>
	<li>Cytosorbents Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTSO#NASDAQ">CTSO</a>) gained 7.2% to $7.88 after the company received full FDA approval for its U.S. STAR-T trial on ticagrelor removal during cardiothoracic surgery.</li>
	<li>Cano Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CANO#NYSE">CANO</a>) rose 4% to $12.50 in pre-market trading as the company said it has acquired Doctor&#39;s Medical Center for $300 million.</li>
</ul>

 
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>

<h3>Losers</h3>

<ul>
	<li>Pop Culture Group Co., Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPOP#NASDAQ">CPOP</a>) dipped 33.7% to $35.40 after dropping over 10% on Friday. Pop Culture Group recently priced its IPO at $6 per share.</li>
	<li>Provention Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRVB#NASDAQ">PRVB</a>) shares dipped 29.6% to $5.84. The FDA has issued a Complete Response Letter (CRL) to Provention Bio&rsquo;s teplizumab marketing application seeking approval for the delay of clinical type 1 diabetes (T1D) in at-risk individuals.</li>
	<li>Ashford Hospitality Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AHT#NYSE">AHT</a>) dropped 27.8% to $2.86 after the company announced preliminary Q2 RevPAR results.</li>
	<li>DiDi Global Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIDI#NYSE">DIDI</a>) shares declined 23.3% to $11.91 after the company announced its app is being removed from Chinese app stores due to personal data collection concerns by the Chinese government.</li>
	<li>Full Truck Alliance Co. Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YMM#NYSE">YMM</a>) shares fell 20.1% to $15.19. The company, last month, priced its IPO at $19 per ADS.</li>
	<li>DouYu International Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOYU#NASDAQ">DOYU</a>) dropped 14.3% to $5.70. Shares of Chinese companies traded lower amid regulatory concerns after Chinese regulators suggested Didi delay its US IPO said they will step up regulation on Chinese firms listed offshore.</li>
	<li>HUTCHMED (China) Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCM#NASDAQ">HCM</a>) dipped 14% to $34.71. HUTCHMED said it initiated Phase I trials of novel ERK inhibitor HMPL 295 in patients with advanced solid tumors in China.</li>
	<li>Zhihu Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZH#NYSE">ZH</a>) fell 13.9% to $10.76. Shares of Chinese companies traded lower amid regulatory concerns after Chinese regulators suggested Didi delay its US IPO said they will step up regulation on Chinese firms listed offshore.</li>
	<li>UP Fintech Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIGR#NASDAQ">TIGR</a>) tumbled 13.1% to $22.23. Shares of Chinese companies traded lower amid regulatory concerns after Chinese regulators suggested Didi delay its US IPO said they will step up regulation on Chinese firms listed offshore.</li>
	<li>Staffing 360 Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STAF#NASDAQ">STAF</a>) shares fell 13% to $4.34 after jumping around 35% on Friday.</li>
	<li>Limelight Networks, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LLNW#NASDAQ">LLNW</a>) dropped 12.5% to $2.71. Goldman Sachs analyst Brett Feldman downgraded the rating on edge cloud services provider Limelight Networks from Neutral to Sell.</li>
	<li>Stride, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LRN#NYSE">LRN</a>) shares declined 12.1% to $28.64.</li>
	<li>Alterity Therapeutics Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATHE#NASDAQ">ATHE</a>) fell 12% to $1.5410. Alterity Therapeutics recently announced it was granted a new US patent targeting major neurodegenerative diseases including Alzheimer&#39;s and Parkinson&#39;s..</li>
	<li>Tuya Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TUYA#NYSE">TUYA</a>) dipped 11.6% to $22.13.</li>
	<li>Kanzhun Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZ#NASDAQ">BZ</a>) fell 11.4% to $32.17.</li>
	<li>Tata Motors Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTM#NYSE">TTM</a>) shares fell 10.7% to $20.62. Jaguar Land Rover reduced its estimates for deliveries to car dealers.</li>
	<li>Auddia Inc.(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) shares fell 10.1% to $6.67. Auddia recently announced the release and national launch of its flagship Auddia app ahead of schedule.</li>
	<li>Clover Health Investments, Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLOV#NASDAQ">CLOV</a>) dropped 9.9% to $10.55.</li>
	<li>Tencent Music Entertainment Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TME#NYSE">TME</a>) fell 9.8% to $13.63.</li>
	<li>Missfresh Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MF#NASDAQ">MF</a>) shares declined 8% to $7.90. The company recently priced its IPO at $13 per share.</li>
</ul>

42 Stocks Moving In Tuesday's Mid-Day Session

&nbsp;

<h3>Gainers</h3>

<ul>
	<li>BSQUARE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSQR#NASDAQ">BSQR</a>) shares moved upwards by 71.23% to $6.82 during Tuesday&#39;s regular session. Trading volume for BSQUARE&#39;s stock is 105.5 million as of 12:30 EST. This is 2031.62% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $91.3 million.</li>
	<li>PFSweb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFSW#NASDAQ">PFSW</a>) shares rose 35.27% to $10.24. As of 12:30 EST, this security is trading at a volume of 3.0 million shares, making up 2437.44% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $216.0 million.</li>
	<li>Bridgeline Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLIN#NASDAQ">BLIN</a>) stock rose 35.06% to $12.12. As of 12:30 EST, Bridgeline Digital&#39;s stock is trading at a volume of 68.8 million, which is 1210.77% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $78.1 million.</li>
	<li>Powerbridge Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBTS#NASDAQ">PBTS</a>) shares increased by 23.88% to $2.23. As of 12:30 EST, Powerbridge Technologies&#39;s stock is trading at a volume of 5.1 million, which is 255.47% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $102.2 million.</li>
	<li>Data Storage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTST#NASDAQ">DTST</a>) shares increased by 17.32% to $6.88. The current volume of 2.5 million shares is 2042.68% of Data Storage&#39;s average full-day volume over the last 100 days (last updated at 12:30 EST). The company&#39;s market cap stands at $33.4 million.</li>
	<li>Research Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RSSS#NASDAQ">RSSS</a>) shares rose 9.7% to $3.0. The current volume of 295.0K shares is 451.14% of Research Solutions&#39;s average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $78.9 million.</li>
</ul>

&nbsp;

&nbsp;

<h3>Losers</h3>

&nbsp;

<ul>
	<li>Limelight Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LLNW#NASDAQ">LLNW</a>) stock fell 13.38% to $2.69 during Tuesday&#39;s regular session. Trading volume for this security as of 12:30 EST is 4.0 million, which is 193.52% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $337.5 million.</li>
	<li>Tuya (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TUYA#NYSE">TUYA</a>) shares decreased by 10.78% to $22.35. Trading volume for this security as of 12:30 EST is 1.3 million, which is 150.82% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $12.5 billion.</li>
	<li>Infobird Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IFBD#NASDAQ">IFBD</a>) stock fell 10.48% to $3.63. Trading volume for this security as of 12:30 EST is 975.1K, which is 39.54% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $91.5 million.</li>
	<li>Movano (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOVE#NASDAQ">MOVE</a>) stock fell 10.0% to $4.86. The current volume of 30.0K shares is 68.99% of Movano&#39;s average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $159.2 million.</li>
	<li>Auddia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) shares decreased by 9.77% to $6.7. As of 12:30 EST, this security is trading at a volume of 2.1 million shares, making up 81.86% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $75.6 million.</li>
	<li>Data I/O (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAIO#NASDAQ">DAIO</a>) stock decreased by 8.56% to $6.09. Data I/O&#39;s stock is trading at a volume of 116.2K shares as of 12:30 EST. This is 257.09% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $51.3 million.</li>
</ul>

&nbsp;

&nbsp;

Auddia Shares Halted On Circuit Breaker; Up 7%

Auddia Shares Resume Trading, Continue Higher

<h3>Gainers</h3>

<ul>
	<li>BSQUARE Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSQR#NASDAQ">BSQR</a>) shares climbed 77.1% to close at $7.05 on Tuesday on abnormally-high volume. The company&rsquo;s stock dropped around 10% on Friday.</li>
	<li>Orbsat Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSAT#NASDAQ">OSAT</a>) shares climbed 54.4% to close at $8.40 on Tuesday on abnormally-high volume.</li>
	<li>PFSweb, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFSW#NASDAQ">PFSW</a>) surged 42.7% to close at $10.80 after the company agreed to sell LiveArea business to Merkle for $250 million.</li>
	<li>Newegg Commerce, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEGG#NASDAQ">NEGG</a>) gained 41.7% to settle at $27.20 on increased volume.</li>
	<li>Red Cat Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCAT#NASDAQ">RCAT</a>) surged 37.4% to close at $3.49.</li>
	<li>Bridgeline Digital, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLIN#NASDAQ">BLIN</a>) shares gained 36.3% to settle at $12.23 after jumping 56% on Friday. Bridgeline Digital, last week, announced its partner network won more than 20 site search licenses this quarter for Celebros and HawkSearch, its most recent acquisition.</li>
	<li>Bon Natural Life Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BON#NASDAQ">BON</a>) jumped 26.5% to settle at $10.18 after the company received the certificate of a land use right for the future site of its third production facility in the city of Yumen.</li>
	<li>Data Storage Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTST#NASDAQ">DTST</a>) jumped 24.4% to close at $7.29 on above-average volume.</li>
	<li>GasLog Partners LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLOP#NYSE">GLOP</a>) gained 23% to settle at $5.03.</li>
	<li>Advaxis, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADXS#NASDAQ">ADXS</a>) shares jumped 23.3% to close at $0.5820 after the company announced it entered into a definitive merger agreement with Biosight and Biosight shareholders will become majority shareholders in the combined company.</li>
	<li>SilverSun Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSNT#NASDAQ">SSNT</a>) gained 20.5% to settle at $14.09.</li>
	<li>Amesite Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMST#NASDAQ">AMST</a>) gained 19.8% to settle at $2.85.</li>
	<li>Evolving Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVOL#NASDAQ">EVOL</a>) surged 19.6% to close at $2.68.</li>
	<li>Marin Software Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) gained 19% to close at $24.14 after climbing around 35% on Friday amid continued extreme volatility and volume in the stock from investors following the company&#39;s Instacart Ads integration announcement.</li>
	<li>Tempest Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPST#NASDAQ">TPST</a>) jumped 18% to settle at $13.24. Piper Sandler initiated coverage on Tempest Therapeutics with an Overweight rating and announced a price target of $23.</li>
	<li>Cytosorbents Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTSO#NASDAQ">CTSO</a>) climbed 17.4% to close at $8.63 after the company received full FDA approval for its U.S. STAR-T trial on ticagrelor removal during cardiothoracic surgery.</li>
	<li>Khosla Ventures Acquisition Co. II (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KVSB#NASDAQ">KVSB</a>) surged 16% to settle at $11.50. Nextdoor announced a deal with Khosla Ventures Acquisition Co. II that values the company at a pro forma equity value of $4.3 billion.</li>
	<li>Larimar Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRMR#NASDAQ">LRMR</a>) gained 15.6% to close at $11.43.</li>
	<li>Qumu Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUMU#NASDAQ">QUMU</a>) gained 15.3% to close at $3.32.</li>
	<li>Kraton Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRA#NYSE">KRA</a>) climbed 14.9% to settle at $36.37. Reuters reported that Kraton is exploring a sale of company.</li>
	<li>Research Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RSSS#NASDAQ">RSSS</a>) gained 14.7% to close at $3.13.</li>
	<li>Taiwan Liposome Company, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLC#NASDAQ">TLC</a>) climbed 14.7% to close at $6.57. TLC recently announced details of stock swap transactions.</li>
	<li>Support.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPRT#NASDAQ">SPRT</a>) gained 12.3% to settle at $4.92.</li>
	<li>Alector, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALEC#NASDAQ">ALEC</a>) rose 12% to close at $39.44. Alector and GlaxoSmithKline recently announced a global collaboration for the development and commercialization of two monoclonal antibodies designed to elevate progranulin (PGRN) levels.</li>
	<li>Connect Biopharma Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTB#NASDAQ">CNTB</a>) jumped 11.5% to close at $21.98. CICC, last week, initiated coverage on Connect Biopharma with an Outperform rating and announced a price target of $27.</li>
	<li>Axcella Health Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXLA#NASDAQ">AXLA</a>) gained 8.6% to close at $4.31 after HC Wainwright &amp; Co initiated coverage on the stock with a Buy rating and a $14 price target.</li>
	<li>Odonate Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODT#NASDAQ">ODT</a>) shares rose 8.4% to close at $3.76 following 13G from Ikarian Capital showing a 5.2% stake in the company.</li>
	<li>Sequential Brands Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SQBG#NASDAQ">SQBG</a>) shares gained 8.2% to settle at $16.98 after jumping 89% on Friday.</li>
	<li>Cleveland BioLabs, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBLI#NASDAQ">CBLI</a>) gained 7.4% to close at $6.24. The company today conducted a merger vote.</li>
	<li>Atossa Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATOS#NASDAQ">ATOS</a>) rose 6% to close at $5.69 after dropping 16% on Friday.</li>
</ul>

&nbsp;

&nbsp;

&nbsp;

<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>

<h3> 
Losers</h3>

<ul>
	<li>Pop Culture Group Co., Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPOP#NASDAQ">CPOP</a>) shares tumbled 40.9% to close at $31.54 on Tuesday after dropping over 10% on Friday. Pop Culture Group recently priced its IPO at $6 per share.</li>
	<li>Ashford Hospitality Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AHT#NYSE">AHT</a>) declined 35.9% to close at $6.11 after the company announced preliminary Q2 RevPAR results.</li>
	<li>Provention Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRVB#NASDAQ">PRVB</a>) shares fell 26.4% to close at $6.11. The FDA has issued a Complete Response Letter (CRL) to Provention Bio&rsquo;s teplizumab marketing application seeking approval for the delay of clinical type 1 diabetes (T1D) in at-risk individuals.</li>
	<li>DiDi Global Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIDI#NYSE">DIDI</a>) shares fell 19.6% to close at $12.49 after the company announced its app is being removed from Chinese app stores due to personal data collection concerns by the Chinese government.</li>
	<li>Wheeler Real Estate Investment Trust, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WHLR#NASDAQ">WHLR</a>) dropped 19.6% to close at $4.10.</li>
	<li>Astra Space, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTR#NASDAQ">ASTR</a>) fell 19.4% to settle at $12.47.</li>
	<li>DouYu International Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOYU#NASDAQ">DOYU</a>) fell 16.4% to close at $5.55. Shares of Chinese companies traded lower amid regulatory concerns after Chinese regulators suggested Didi delay its US IPO said they will step up regulation on Chinese firms listed offshore.</li>
	<li>Kanzhun Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZ#NASDAQ">BZ</a>) shares dipped 16% to close at $30.52.</li>
	<li>Zhihu Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZH#NYSE">ZH</a>) declined 15.3% to close at $10.60. Shares of Chinese companies traded lower amid regulatory concerns after Chinese regulators suggested Didi delay its US IPO said they will step up regulation on Chinese firms listed offshore.</li>
	<li>Ra Medical Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RMED#NYSE">RMED</a>) dropped 15.3% to settle at $4.00.</li>
	<li>Creatd, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRTD#NASDAQ">CRTD</a>) dipped 15.2% to close at $3.18.</li>
	<li>Clover Health Investments, Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLOV#NASDAQ">CLOV</a>) fell 14.6% to close at $10.00.</li>
	<li>Passage Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PASG#NASDAQ">PASG</a>) dipped 14.6% to settle at $13.26. Raymond James, last week, initiated coverage on the stock with an Outperform rating and announced a $29 price target.</li>
	<li>UP Fintech Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIGR#NASDAQ">TIGR</a>) fell 14.4% to close at $21.89. Shares of Chinese companies traded lower amid regulatory concerns after Chinese regulators suggested Didi delay its US IPO said they will step up regulation on Chinese firms listed offshore.</li>
	<li>Werewolf Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOWL#NASDAQ">HOWL</a>) fell 14.2% to close at $17.43.</li>
	<li>Beam Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAM#NASDAQ">BEAM</a>) fell 13.2% to settle at $112.97. Shares of gene editing companies traded lower, selling off after the sector surged last week following positive data from Intellia.</li>
	<li>Birks Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BGI#NYSE">BGI</a>) fell 12.9% to close at $2.56. Birks Group recently announced all 29 of the Company&rsquo;s retail stores across Canada are now open for in-person shopping.</li>
	<li>CVRx, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVRX#NASDAQ">CVRX</a>) dropped 12.9% to settle at $22.17. The company recently priced its IPO at $18 per share.</li>
	<li>IKONICS Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IKNX#NASDAQ">IKNX</a>) fell 12.8% to close at $20.45.</li>
	<li>PureCycle Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCT#NASDAQ">PCT</a>) dropped 12.4% to settle at $19.86.</li>
	<li>Stride, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LRN#NYSE">LRN</a>) shares declined 12.2% to close at $28.63.</li>
	<li>Tata Motors Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTM#NYSE">TTM</a>) shares fell 11.8% to close at $20.33. Jaguar Land Rover reduced its estimates for deliveries to car dealers.</li>
	<li>HUTCHMED (China) Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCM#NASDAQ">HCM</a>) fell 11.6% to close at $35.66. HUTCHMED said it initiated Phase I trials of novel ERK inhibitor HMPL 295 in patients with advanced solid tumors in China.</li>
	<li>Sharecare, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHCR#NASDAQ">SHCR</a>) dropped 11.3% to close at $8.28.</li>
	<li>Perpetua Resources Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPTA#NASDAQ">PPTA</a>) declined 9.7% to settle at $6.73.</li>
	<li>Tuya Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TUYA#NYSE">TUYA</a>) fell 8.7% to close at $22.88.</li>
	<li>Limelight Networks, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LLNW#NASDAQ">LLNW</a>) slipped 8.1% to settle at $2.85. Goldman Sachs analyst Brett Feldman downgraded the rating on edge cloud services provider Limelight Networks from Neutral to Sell.</li>
	<li>Auddia Inc.(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) shares fell 7.4% to close at $6.87. Auddia recently announced the release and national launch of its flagship Auddia app ahead of schedule.</li>
	<li>Tencent Music Entertainment Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TME#NYSE">TME</a>) fell 6.8% to close at $14.10.</li>
	<li>Full Truck Alliance Co. Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YMM#NYSE">YMM</a>) shares slipped 6.7% to close at $17.75. The company, last month, priced its IPO at $19 per ADS.</li>
	<li>Alterity Therapeutics Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATHE#NASDAQ">ATHE</a>) fell 5.1% to close at $1.66. Alterity Therapeutics recently announced it was granted a new US patent targeting major neurodegenerative diseases including Alzheimer&#39;s and Parkinson&#39;s..</li>
</ul>

61 Biggest Movers From Yesterday

<h3>Gainers</h3>

<ul>
	<li>Newegg Commerce, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEGG#NASDAQ">NEGG</a>) shares surged 148.4% to close at $67.57 on Wednesday after jumping around 42% on Tuesday.</li>
	<li>Mannatech, Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEX#NASDAQ">MTEX</a>) gained 49.7% to settle at $43.71 on Wednesday.</li>
	<li>Data Storage Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTST#NASDAQ">DTST</a>) shares climbed 32.8% to close at $9.68. Data Storage shares jumped over 24% on Tuesday on above-average volume.</li>
	<li>iPower Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPW#NASDAQ">IPW</a>) gained 32.2% to settle at $7.72.</li>
	<li>Peabody Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTU#NYSE">BTU</a>) gained 24.5% to close at $10.01, possibly amid an increase in the price of coal stemming from China unofficially banning Australian coal imports and rising demand in other countries as economies reopen from the pandemic.</li>
	<li>Dar&eacute; Bioscience, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DARE#NASDAQ">DARE</a>) jumped 23.7% to settle at $1.88 on a report suggesting the company entered into an agreement with the Bill &amp; Melinda Gates Foundation and were awarded a new grant of up to $48.95 million to support development of DARE-LARC1.</li>
	<li>Vivos Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VVOS#NASDAQ">VVOS</a>) surged 23.5% to close at $5.20 after an independent study showed 97% of Vivos patients achieved their desired treatment outcome.</li>
	<li>Exela Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XELA#NASDAQ">XELA</a>) jumped 22.8% to settle at $3.29. Exela Technologies said recently-announced at-the-market equity program raised $85 million of proceeds.</li>
	<li>OncoSec Medical Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONCS#NASDAQ">ONCS</a>) shares gained 21.9% to settle at $3.40 after the company said it will evaluate its DNA-plasmid interleukin-12 (IL-12) TAVO (tavokinogene telseplasmid) with Merck &amp; Co&rsquo;s Keytruda (pembrolizumab) in KEYNOTE-C87 Phase 3 trial.</li>
	<li>Opiant Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPNT#NASDAQ">OPNT</a>) shares jumped 21.6% to close at $16.12 after the company disclosed top-line results from its confirmatory pharmacokinetic study for OPNT003, nasal nalmefene, for opioid overdose.</li>
	<li>SMART Global Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGH#NASDAQ">SGH</a>) gained 17.8% to settle at $56.02 after the company reported better-than-expected Q3 results. The company also issued Q4 guidance above analyst estimates.</li>
	<li>G Medical Innovations Holdings Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMVD#NASDAQ">GMVD</a>) rose 17.6% to close at $4.34. The company, last month priced its IPO at $5 per unit.</li>
	<li>Digital Brands Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DBGI#NASDAQ">DBGI</a>) gained 17.1% to settle at $5.27.</li>
	<li>Virpax Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) climbed 13.9% to close at $5.18 after the company issued a progress update on product candidates.</li>
	<li>Biohaven Pharmaceutical Holding Company Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHVN#NYSE">BHVN</a>) climbed 13.6% to settle at $112.25. Biohaven reported Q2 NURTEC ODT sales of $93 million.</li>
	<li>X Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYF#NYSE">XYF</a>) rose 13% to close at $13.13.</li>
	<li>Grom Social Enterprises, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GROM#NASDAQ">GROM</a>) gained 12.8% to settle at $4.05. The company said Curiosity and global production and distribution powerhouse Toon2Tango GmbH &amp; Co. KG will develop Santa.com into an original animated musical holiday special.</li>
	<li>KBS Fashion Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KBSF#NASDAQ">KBSF</a>) gained 12.4% to close at $4.44.</li>
	<li>IVERIC bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISEE#NASDAQ">ISEE</a>) surged 11.9% to close at $9.61. IVERIC recently announced it received written agreement from the FDA under a Special Protocol Assessment for the overall design of the company&#39;s GATHER2 Phase 3 trial of Zimura.</li>
	<li>Bon Natural Life Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BON#NASDAQ">BON</a>) rose 11% to settle at $11.30. Bon Natural Life recently received the certificate of a land use right for the future site of its third production facility in the city of Yumen.</li>
	<li>Nova LifeStyle, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVFY#NASDAQ">NVFY</a>) gained 10.8% to close at $3.79.</li>
	<li>JinkoSolar Holding Co., Ltd(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JKS#NYSE">JKS</a>) shares climbed 10.7% to settle at $60.14 after gaining around 8% on Tuesday.</li>
	<li>INmune Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INMB#NASDAQ">INMB</a>) jumped 10.6% to close at $19.75.</li>
	<li>CareMax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMAX#NASDAQ">CMAX</a>) gained 9.7% to settle at $13.80. CareMax recently entered into an agreement to acquire DNF Medical Centers.</li>
	<li>Femasys Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEMY#NASDAQ">FEMY</a>) surged 9.3% to settle at $7.75. The company, lats month, priced its IPO at $13 a share.</li>
	<li>Performant Financial Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFMT#NASDAQ">PFMT</a>) gained 9.1% to close at $3.71. Craig-Hallum initiated coverage on Performant Financial with a Buy rating and announced a price target of $10.</li>
	<li>iSpecimen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPC#NASDAQ">ISPC</a>) gained 8.1% to close at $6.70. The company, last month, priced its IPO at $8 per share.</li>
</ul>

&nbsp;

 
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>

<h3>Losers</h3>

<ul>
	<li>Bridgeline Digital, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLIN#NASDAQ">BLIN</a>) shares tumbled 30.1% to close at $8.55 on Wednesday. Bridgeline Digital reported that a global footwear brand&#39;s Indonesian subsidiary chose the company&rsquo;s Celebros search for online experience.</li>
	<li>BSQUARE Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSQR#NASDAQ">BSQR</a>) dropped 28.4% to close at $5.05. On July 6, 2021, software solutions provider BSQUARE entered into a Side Letter with B. Riley Securities, Inc to sell shares having an aggregate offering price of up to $50 million under the company&rsquo;s Form S-3 filed on March 18.</li>
	<li>Professional Diversity Network, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPDN#NASDAQ">IPDN</a>) dipped 20.8% to close at $1.68 after the company reported a $2.5 million registered direct offering at $1.70 per share.</li>
	<li>Eco Wave Power Global AB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WAVE#NASDAQ">WAVE</a>) dropped 20.4% to settle at $14.85. A 13G filing from Alpha Capital recently showed an 8.7% stake in the company.</li>
	<li>Marin Software Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) fell 20.3% to close at $19.24 after gaining gained 19% on Tuesday amid continued extreme volatility and volume in the stock from investors following the company&#39;s Instacart Ads integration announcement..</li>
	<li>IDEAYA Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDYA#NASDAQ">IDYA</a>) declined 20.3% to close at $18.11 after the company offered up to $80 million shares in an underwritten public offering. Underwriters have an option to purchase up to $12 million of shares.</li>
	<li>Staffing 360 Solutions Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STAF#NASDAQ">STAF</a>) dipped 20.2% to close at $3.83 after declining around 4% on Tuesday.</li>
	<li>Meta Materials Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMAT#NASDAQ">MMAT</a>) dropped 19.3% to settle at $5.80. Meta Materials, formerly known as Torchlight Energy Resources Inc, recently performed a reverse split and merged with the company Meta Materials Inc. to become a combined company under the ticker MMAT.</li>
	<li>Cleveland BioLabs, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBLI#NASDAQ">CBLI</a>) fell 18.9% to close at $5.06. Cleveland BioLabs and Cytocom recently announced a call to discuss the stockholder meeting vote results and proposed merger.</li>
	<li>Mercurity Fintech Holding Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MFH#NASDAQ">MFH</a>) dropped 18.5% to close at $4.20.</li>
	<li>Powerbridge Technologies Co Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBTS#NASDAQ">PBTS</a>) declined 18.4% to settle at $2.49 after surging around 70% on Tuesday.</li>
	<li>iClick Interactive Asia Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICLK#NASDAQ">ICLK</a>) fell 17.6% to close at $8.92.</li>
	<li>SemiLEDs Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEDS#NASDAQ">LEDS</a>) dipped 17.6% to settle at $13.50. SemiLEDs said, on July 6, it entered into a sales agreement with Roth Capital Partners.</li>
	<li>Tempest Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPST#NASDAQ">TPST</a>) fell 17.5% to close at $10.93. Piper Sandler recently initiated coverage on Tempest Therapeutics with an Overweight rating and announced a price target of $23.</li>
	<li>Red Cat Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCAT#NASDAQ">RCAT</a>) shares dropped 16.9% to close at $2.90 after climbing over 37% on Tuesday.</li>
	<li>Pop Culture Group Co Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPOP#NASDAQ">CPOP</a>) shares declined 16.7% to close at $26.26. Pop Culture Group shares dropped over 40% on Tuesday on continued post-IPO volatility.</li>
	<li>Wheeler Real Estate Investment Trust, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WHLR#NASDAQ">WHLR</a>) dropped 16.6% to close at $3.42 after declining 20% on Tuesday.</li>
	<li>Manhattan Bridge Capital, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOAN#NASDAQ">LOAN</a>) dropped 16.1% to close at $6.65 as the company priced its 1.875 million share offering $7.20 per share.</li>
	<li>Soligenix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNGX#NASDAQ">SNGX</a>) dropped 16% to settle at $1.10 after jumping 26% on Tuesday.</li>
	<li>Auddia Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) fell 15.4% to close at $5.81. Auddia recently named RadioAlabama as the third radio station group on the Auddia platform.</li>
	<li>Amesite Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMST#NASDAQ">AMST</a>) shares dropped 14.4% to close at $2.44 after jumping around 20% on Tuesday.</li>
	<li>Ocean Power Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OPTT#NYSE">OPTT</a>) fell 14.1% to close at $2.43.</li>
	<li>ACM Research, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACMR#NASDAQ">ACMR</a>) dropped 13.9% to settle at $84.23.</li>
	<li>Novavax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) dipped 13.7% to close at $185.78.</li>
	<li>Support.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPRT#NASDAQ">SPRT</a>) dropped 13.2% to settle at $4.27.</li>
	<li>Synaptogenix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPX#NASDAQ">SNPX</a>) fell 13.2% to close at $8.45. Synaptogenix announced a regenerative patent award to treat Alzheimer&#39;s disease.</li>
	<li>Zhihu Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZH#NYSE">ZH</a>) tumbled 12.7% to settle at $9.25.</li>
	<li>Sequential Brands Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SQBG#NASDAQ">SQBG</a>) fell 12.1% to close at $14.92. Sequential Brands gained 8% on Tuesday on above-average volume.</li>
	<li>Cuentas Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CUEN#NASDAQ">CUEN</a>) dipped 11.7% to close at $5.31.</li>
	<li>Orbsat Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSAT#NASDAQ">OSAT</a>) shares declined 10.8% to close at $7.49. Orbsat shares climbed 54% on Tuesday on abnormally-high volume.</li>
	<li>Qumu Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUMU#NASDAQ">QUMU</a>) slipped 9.9% to close at $2.99 after gaining 15% on Tuesday.</li>
	<li>Portage Biotech Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTG#NASDAQ">PRTG</a>) dropped 8.7% to close at $19.43. Portage Biotech was recently added to Russell 2000 Index.</li>
	<li>Axcella Health Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXLA#NASDAQ">AXLA</a>) dropped 7.2% to close at $4.00. Axcella Health gained around 9% on Tuesday after HC Wainwright &amp; Co initiated coverage on the stock with a Buy rating and a $14 price target.</li>
	<li>Nikola Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKLA#NASDAQ">NKLA</a>) shares slipped 6.8% to close at $15.28. CNH Industrial recently announced a partnership with Nikola.</li>
</ul>

<h3>Gainers</h3>
<ul>
<li>Exela Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XELA#NASDAQ">XELA</a>) stock moved upwards by 4.61% to $3.63 during Monday's after-market session. Trading volume for this security closed at 4.1 million, accounting for 12.36% of its average full-day volume over the last 100 days. The company's market cap stands at $214.8 million. </li>
<li>Color Star Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCW#NASDAQ">CSCW</a>) stock increased by 3.4% to $1.03. Color Star Technology's trading volume hit 2.4K shares by close, accounting for 0.06% of its average volume over the last 100 days. The company's market cap stands at $93.0 million. </li>
<li>OLB Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLB#NASDAQ">OLB</a>) shares rose 2.22% to $6.88. Trading volume for this security closed at 10.7K, accounting for 7.36% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $48.9 million. </li>
<li>Limelight Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LLNW#NASDAQ">LLNW</a>) shares rose 2.17% to $2.82. Trading volume for this security closed at 60.5K, accounting for 2.82% of its average full-day volume over the last 100 days. The company's market cap stands at $354.4 million. </li>
<li>Auddia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) shares increased by 2.01% to $5.07. Trading volume for this security closed at 759, accounting for 0.03% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $62.6 million. </li>
<li>Marin Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) stock increased by 1.73% to $14.7. Marin Software's trading volume hit 22.6K shares by close, accounting for 0.1% of its average volume over the last 100 days. The market value of their outstanding shares is at $161.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Cemtrex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETX#NASDAQ">CETX</a>) shares decreased by 3.58% to $1.89 during Monday's after-market session. At the close, Cemtrex's trading volume reached 742.0K shares. This is 142.12% of its average volume over the last 100 days. The company's market cap stands at $35.3 million. </li>
<li>SGOCO Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGOC#NASDAQ">SGOC</a>) stock decreased by 2.5% to $19.5. SGOCO Group's trading volume hit 321.6K shares by close, accounting for 14.88% of its average volume over the last 100 days. The company's market cap stands at $1.9 billion. </li>
<li>Tufin Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TUFN#NYSE">TUFN</a>) stock declined by 1.72% to $10.89. Tufin Software's trading volume hit 46.4K shares by close, accounting for 20.89% of its average volume over the last 100 days. The company's market cap stands at $400.4 million. </li>
<li>Data Storage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTST#NASDAQ">DTST</a>) stock decreased by 1.72% to $8.01. Data Storage's trading volume hit 6.5K shares by close, accounting for 0.52% of its average volume over the last 100 days. The market value of their outstanding shares is at $38.9 million. </li>
<li>Aehr Test Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHR#NASDAQ">AEHR</a>) stock decreased by 1.67% to $2.95. Trading volume for this security closed at 2.1K, accounting for 0.57% of its average full-day volume over the last 100 days. The company's market cap stands at $69.6 million. </li>
<li>Agora (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/API#NASDAQ">API</a>) shares decreased by 1.54% to $37.13. Today's trading volume for this security ended up closing at 6.0K shares, which is 0.51 percent of its average volume over the last 100 days. The company's market cap stands at $4.3 billion. </li>
</ul>

12 Information Technology Stocks Moving In Monday's After-Market Session

<h3>Gainers</h3>

<ul>
	<li>SGOCO Group, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGOC#NASDAQ">SGOC</a>) shares gained 37.6% to settle at $13.20 on Wednesday. SGOCO Group regained compliance with Nasdaq&#39;s listing standards on July 12 by filing its FY20 20-F.</li>
	<li>Datasea Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTSS#NASDAQ">DTSS</a>) shares jumped 35.8% to close at $3.98 on Wednesday. Datasea&rsquo;s subsidiary Shuhai Zhangxun Information Technology Co., Ltd inked six purchase and distribution agreements to provide 5G Message-marketing Cloud Platform (5G MMCP) Version 3.0 and further enhanced product availability nationwide in China by adding new district partners..</li>
	<li>Bon Natural Life Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BON#NASDAQ">BON</a>) gained 33.6% to settle at $11.89.</li>
	<li>Virpax Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) jumped 30.6% to close at $7.38.</li>
	<li>Wilhelmina International, Inc.. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WHLM#NASDAQ">WHLM</a>) shares rose 24.7% to close at $6.16.</li>
	<li>Kura Sushi USA, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRUS#NASDAQ">KRUS</a>) gained 23.2% to close at $47.51 after the company reported third-quarter sales growth of 557% year-on-year to $18.47 million, beating the consensus of $15.49 million.</li>
	<li>CorePoint Lodging Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPLG#NYSE">CPLG</a>) jumped 21.8% to close at $13.45. CorePoint Lodging issued Q2 business update and announced exploration of strategic alternatives.</li>
	<li>U.S. Energy Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USEG#NASDAQ">USEG</a>) gained 21.2% to settle at $5.04.</li>
	<li>GBS Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GBS#NASDAQ">GBS</a>) climbed 16.9% to close at $4.29. GBS was recently awarded a $4.7 million Australian Federal Government scientific grant to manufacture biosensor technology.</li>
	<li>Wheels Up Experience Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UP#NYSE">UP</a>) gained 16.3% to settle at $11.55 on its first day of trading under its new name and ticker after a SPAC merger,</li>
	<li>Westwood Holdings Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WHG#NYSE">WHG</a>) jumped 16% to close at $22.68. Wealth manager Americana Partners announced a $25 per share offer for Westwood Holdings Group, Reuters reported.</li>
	<li>Compass Minerals International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMP#NYSE">CMP</a>) surged 13.2% to close at $68.43 after the company announced it identified approximately 2.4 million metric tons of sustainable lithium resource. CL King upgraded Compass Minerals Intl from Neutral to Buy and announced a $75 price target.</li>
	<li>Minim, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MINM#NASDAQ">MINM</a>) jumped 12.8% to close at $4.50.</li>
	<li>Verb Technology Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERB#NASDAQ">VERB</a>) gained 12.2% to close at $2.49. SHOP.COM and Verb announced plans to launch SHOP LIVE Live-streaming channel.</li>
	<li>Ashford Hospitality Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AHT#NYSE">AHT</a>) shares rose 10.8% to settle at $2.15 after declining 12% on Tuesday. Ashford Hospitality Trust recently announced preliminary Q2 RevPAR results.</li>
	<li>Yunhong CTI Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTIB#NASDAQ">CTIB</a>) rose 10.7% to settle at $2.89.</li>
	<li>Covanta Holding Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVA#NYSE">CVA</a>) surged 7.4% to close at $19.95. Covanta agreed to be acquired by EQT Infrastructure for $20.25 per share. The purchase price represents an approximately 37% premium to Covanta&#39;s share price of $14.78 on June 8th, 2021, and a 9% premium to the $18.57 closing price on July 13th, 2021.</li>
	<li>Peabody Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTU#NYSE">BTU</a>) gained 6.2% to close at $11.00.</li>
	<li>Oxbridge Re Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OXBR#NASDAQ">OXBR</a>) shares rose 5.7% to close at $3.54 after Custodian Ventures disclosed a 9.9% active stake in the company.</li>
	<li>Jefferies Financial Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JEF#NYSE">JEF</a>) gained 5.4% to close at $33.64. Jefferies and SMBC announced alliance to &#39;collaborate on future corporate and investment banking business opportunities.&#39;</li>
</ul>

 
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>

<h3>Losers</h3>

<ul>
	<li>Allena Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALNA#NASDAQ">ALNA</a>) fell 35% to close at $0.9030 on Wednesday after jumping 14% on Tuesday. Allena Pharmaceuticals recently provided progress updates on its ALLN-346 and reloxaliase (ALLN-177) clinical programs.</li>
	<li>Unicycive Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UNCY#NASDAQ">UNCY</a>) dropped 35% to close at $3.80 on Wednesday. Unicycive Therapeutics surged 17% on Tuesday as the company priced its IPO at $5 a share.</li>
	<li>Allied Healthcare Products, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AHPI#NASDAQ">AHPI</a>) shares tumbled 31.1% to close at $6.24 on Wednesday after jumping around 130% on Tuesday.</li>
	<li>Moving iMage Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MITQ#NASDAQ">MITQ</a>) shares fell 30.4% to close at $5.01 on Wednesday. Moving iMage Technologies recently priced its initial public offering of 4.2 million common shares at $3 per share.</li>
	<li>Antelope Enterprise Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHL#NASDAQ">AEHL</a>) shares fell 25.8% to close at $2.97.</li>
	<li>Auddia Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) dropped 23.8% to close at $4.11.</li>
	<li>Cemtrex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETX#NASDAQ">CETX</a>) fell 23.1% to close at $1.40 after dropping 7% on Tuesday. The company, last month, reported Q2 results.</li>
	<li>Glaukos Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GKOS#NASDAQ">GKOS</a>) tumbled 21.4% to close at $57.82 after William Blair downgraded the stock from Outperform to Market Perform. Centers for Medicare and Medicaid Services (CMS) issued its fiscal 2022 proposed physician fee schedule, which included two combined Category I cataract plus stent procedure codes.</li>
	<li>Prometheus Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXDX#NASDAQ">RXDX</a>) dropped 21.1% to settle at $20.89.</li>
	<li>Clene Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLNN#NASDAQ">CLNN</a>) fell 19.8% to settle at $10.89.</li>
	<li>Recursion Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXRX#NASDAQ">RXRX</a>) shares declined 19.4% to close at $33.31. Recursion recently reported the formation of a Therapeutics Advisory Board.</li>
	<li>Moxian, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOXC#NASDAQ">MOXC</a>) fell 18% to close at $24.00.</li>
	<li>The OLB Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLB#NASDAQ">OLB</a>) dropped 17.4% to settle at $5.69.</li>
	<li>Upwork Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPWK#NASDAQ">UPWK</a>) fell 17.4% to close at $50.15.</li>
	<li>IMARA Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMRA#NASDAQ">IMRA</a>) dipped 16.8% to settle at $5.90 after the company priced its previously announced underwritten public offering of shares at $6.00 per share for gross proceeds of $50 million..</li>
	<li>Baosheng Media Group Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BAOS#NASDAQ">BAOS</a>) declined 16% to close at $2.99.</li>
	<li>TransCode Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAZ#NASDAQ">RNAZ</a>) fell 16% to close at $3.83.</li>
	<li>Xcel Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XELB#NASDAQ">XELB</a>) dropped 15.7% to settle at $2.26.</li>
	<li>SCWorx Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WORX#NASDAQ">WORX</a>) shares declined 15.4% to close at $2.69 after jumping around 20% on Tuesday.</li>
	<li>Bridgeline Digital, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLIN#NASDAQ">BLIN</a>) fell 15.3% to settle at $6.15 amid profit taking after the stock surged on Tuesday.</li>
	<li>AMC Entertainment Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>) dropped 15% to close at $33.43 amid continued profit taking following the stock&#39;s recent retail-driven surge.</li>
	<li>SunPower Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPWR#NASDAQ">SPWR</a>) shares tumbled 14.7% to close at $23.94. SunPower said Woodside Homes is now offering SunPower Solar and SunVault Battery Storage Systems to owners and buyers in northern CA communities.</li>
	<li>B.O.S. Better Online Solutions Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOSC#NASDAQ">BOSC</a>) fell 14.6% to settle at $4.15.</li>
	<li>Nine Energy Service, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NINE#NYSE">NINE</a>) shares fell 14.3% to close at $2.82. Nine Energy Service is scheduled to host its Q2 earnings conference call on Thursday, August 5, 2021.</li>
	<li>Integrated Media Technology Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMTE#NASDAQ">IMTE</a>) declined 14.1% to close at $3.79. Integrated Media Technology recently inked agreements with three accredited investors to raise $2.8 million from the sale of 888,888 shares at $3.15 per share.</li>
	<li>INmune Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INMB#NASDAQ">INMB</a>) fell 13.9% to settle at $22.96 after the company announced a $40 million registered direct offering.</li>
	<li>Sonoma Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNOA#NASDAQ">SNOA</a>) dropped 13.6% to close at $7.68 after gaining 25% on Tuesday.</li>
	<li>Xenetic Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XBIO#NASDAQ">XBIO</a>) shares dipped 13% to close at $2.14 after gaining over 21% on Tuesday.</li>
	<li>ironSource Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IS#NYSE">IS</a>) dropped 13% to close at $8.72.</li>
	<li>Creatd, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRTD#NASDAQ">CRTD</a>) fell 12.8% to close at $4.01 after dropping 18% on Tuesday.</li>
	<li>Sprinklr, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CXM#NYSE">CXM</a>) dropped 12.3% to settle at $19.44.</li>
	<li>Engine Media Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GAME#NASDAQ">GAME</a>) fell 11.3% to close at $7.94. Engine Media&#39;s Frankly Media recently announced Esports Media partnership to &lsquo;monetize digital properties.&rsquo;</li>
	<li>Stable Road Acquisition Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRAC#NASDAQ">SRAC</a>) fell 10.3% to close at $10.66. Traders circulated early Tuesday morning SEC press release titled &#39;SEC Charges SPAC, Sponsor, Merger Target, and CEOs for Misleading Disclosures Ahead of Proposed Business Combination.&#39;</li>
	<li>LeMaitre Vascular, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMAT#NASDAQ">LMAT</a>) dropped 9.2% to close at $54.52 as the company announced preliminary Q2 2021 results and sees net sales of $40.7 million compared to an estimated $37.9 million, up 64%Y/Y on a reported basis and +35% organically. Concurrently, the Company also priced underwritten public offering of 1 million shares at $54.50 per share, with gross proceeds of approximately $54.5 million.</li>
	<li>Aspen Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASPU#NASDAQ">ASPU</a>) fell 7.7% to close at $5.89. Aspen Group reported fourth-quarter sales growth of 35.46% year-on-year to $19.10 million, beating the consensus of $18.51 million. However, net loss per share came in at $0.09.</li>
</ul>

55 Biggest Movers From Yesterday

Shares of several companies in the broader technology sector are trading lower amid overall market weakness as investors weigh recent economic data and comments from Fed Chair Powell on inflation.

&nbsp;

<h3>Gainers</h3>

<ul>
	<li>Smith Micro Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMSI#NASDAQ">SMSI</a>) shares rose 8.25% to $5.9 during Tuesday&#39;s pre-market session. The company&#39;s market cap stands at $315.5 million.</li>
	<li>SeaChange International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEAC#NASDAQ">SEAC</a>) shares moved upwards by 7.61% to $1.13. The market value of their outstanding shares is at $54.6 million.</li>
	<li>Support.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPRT#NASDAQ">SPRT</a>) stock increased by 6.83% to $4.69. The market value of their outstanding shares is at $113.6 million.</li>
	<li>Wrap Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRAP#NASDAQ">WRAP</a>) shares rose 5.34% to $7.1. The market value of their outstanding shares is at $283.0 million.</li>
	<li>Auddia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) shares rose 4.88% to $4.0. The market value of their outstanding shares is at $49.4 million.</li>
	<li>Aehr Test Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHR#NASDAQ">AEHR</a>) stock rose 4.85% to $6.7. The market value of their outstanding shares is at $158.1 million. As per the news, the Q4 earnings report came out 3 days ago.</li>
</ul>

&nbsp;

&nbsp;

<h3>Losers</h3>

&nbsp;

<ul>
	<li>SolarWinds (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SWI#NYSE">SWI</a>) shares fell 37.48% to $10.58 during Tuesday&#39;s pre-market session. The market value of their outstanding shares is at $3.3 billion.</li>
	<li>Intrusion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTZ#NASDAQ">INTZ</a>) shares fell 12.83% to $7.41. The market value of their outstanding shares is at $130.5 million.</li>
	<li>Mechanical Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKTY#NASDAQ">MKTY</a>) shares declined by 6.02% to $6.72. The market value of their outstanding shares is at $85.1 million.</li>
	<li>Datasea (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTSS#NASDAQ">DTSS</a>) stock fell 5.22% to $4.18. The market value of their outstanding shares is at $89.7 million.</li>
	<li>UTime (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UTME#NASDAQ">UTME</a>) shares fell 3.9% to $8.64. The company&#39;s market cap stands at $71.4 million.</li>
	<li>Exela Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XELA#NASDAQ">XELA</a>) shares fell 3.28% to $2.95. The company&#39;s market cap stands at $174.6 million.</li>
</ul>

&nbsp;

&nbsp;

12 Information Technology Stocks Moving In Tuesday's Pre-Market Session

&nbsp;

<h3>Gainers</h3>

<ul>
	<li>Support.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPRT#NASDAQ">SPRT</a>) stock rose 30.3% to $6.45 during Thursday&#39;s regular session. Support.com&#39;s stock is trading at a volume of 19.8 million shares as of 12:30 EST. This is 1103.38% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $156.2 million.</li>
	<li>Summit Wireless (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WISA#NASDAQ">WISA</a>) stock rose 29.96% to $5.29. As of 12:30 EST, Summit Wireless&#39;s stock is trading at a volume of 95.2 million, which is 9631.1% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $67.5 million.</li>
	<li>Sigmatron International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGMA#NASDAQ">SGMA</a>) shares moved upwards by 9.19% to $5.94. As of 12:30 EST, Sigmatron International&#39;s stock is trading at a volume of 1.5 million, which is 971.98% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $25.2 million.</li>
	<li>DLocal (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLO#NASDAQ">DLO</a>) shares rose 6.39% to $49.11. Trading volume for this security as of 12:30 EST is 167.6K, which is 12.38% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $14.3 billion.</li>
	<li>IDEX Biometrics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDBA#NASDAQ">IDBA</a>) shares rose 6.17% to $18.05. The market value of their outstanding shares is at $220.9 million.</li>
	<li>Viant Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSP#NASDAQ">DSP</a>) stock moved upwards by 4.85% to $18.56. Trading volume for this security as of 12:30 EST is 693.0K, which is 203.28% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.0 billion.</li>
</ul>

&nbsp;

&nbsp;

<h3>Losers</h3>

&nbsp;

<ul>
	<li>Marin Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) shares declined by 13.74% to $8.41 during Thursday&#39;s regular session. Trading volume for Marin Software&#39;s stock is 7.5 million as of 12:30 EST. This is 32.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $92.2 million.</li>
	<li>Daqo New Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DQ#NYSE">DQ</a>) shares decreased by 13.66% to $68.54. As of 12:30 EST, Daqo New Energy&#39;s stock is trading at a volume of 8.3 million, which is 317.44% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $5.0 billion.</li>
	<li>Auddia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) shares decreased by 10.71% to $3.29. The current volume of 282.1K shares is 9.0% of Auddia&#39;s average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $40.7 million.</li>
	<li>Datasea (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTSS#NASDAQ">DTSS</a>) shares decreased by 10.62% to $2.61. Datasea&#39;s stock is trading at a volume of 1.1 million shares as of 12:30 EST. This is 35.65% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $56.0 million.</li>
	<li>Netgear (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTGR#NASDAQ">NTGR</a>) shares fell 10.26% to $33.26. Trading volume for this security as of 12:30 EST is 2.1 million, which is 712.61% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.0 billion. As per the news, the Q2 earnings report came out yesterday.</li>
	<li>SemiLEDs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEDS#NASDAQ">LEDS</a>) shares declined by 9.29% to $9.28. Trading volume for SemiLEDs&#39;s stock is 693.8K as of 12:30 EST. This is 8.43% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $38.0 million.</li>
</ul>

&nbsp;

&nbsp;

12 Information Technology Stocks Moving In Thursday's Intraday Session

<h3>Gainers</h3>

<ul>
	<li>ImmunoPrecise Antibodies Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPA#NASDAQ">IPA</a>) shares climbed 129.7% to $12.75 after the company announced new results from its TATX-03 PolyTope Therapy, demonstrating potent pseudovirus neutralizing activity against the SARS-CoV-2 Delta (B.1.617.2) variant.</li>
	<li>NRx Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRXP#NASDAQ">NRXP</a>) shares jumped 44.7% to $14.63 as the company said it has validated the first commercial formulation of Zyesami for intravenous use, allowing for high volume manufacturing, with an anticipated one year or greater stability under appropriate storage conditions.</li>
	<li>PainReform Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRFX#NASDAQ">PRFX</a>) shares gained 30.6% to $4.10.</li>
	<li>Couchbase, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BASE#NASDAQ">BASE</a>) gained 27.5% to $30.60 as the company priced its IPO at $24 per share.</li>
	<li>Applied DNA Sciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APDN#NASDAQ">APDN</a>) gained 23.5% to $6.78.</li>
	<li>Universe Pharmaceuticals INC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) jumped 23% to $3.26 on above-average volume.</li>
	<li>Support.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPRT#NASDAQ">SPRT</a>) surged 22.6% to $6.07 on above-average volume.</li>
	<li>Summit Wireless Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WISA#NASDAQ">WISA</a>) gained 20.4% to $4.9001 after the company highlighted the launch of its Amazon storefront.</li>
	<li>ERYTECH Pharma S.A. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERYP#NASDAQ">ERYP</a>) jumped 18.9% to $5.18. ERYTECH recently confirmed plans to submit Biologics License Application for eryaspase in hypersensitive ALL patients.</li>
	<li>VTEX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTEX#NYSE">VTEX</a>) gained 18.8% to $26.37. VTEX recently priced 19 million shares at $19 per share in its initial public offering.</li>
	<li>Sequential Brands Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SQBG#NASDAQ">SQBG</a>) rose 17.8% to $12.23.</li>
	<li>Neurometrix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NURO#NASDAQ">NURO</a>) rose 15.6% to $24.04 after reporting Q2 earnings. The company recently announced that its Quell device has received Breakthrough Designation from the FDA for treating the symptoms of fibromyalgia in adults.</li>
	<li>Domino&#39;s Pizza, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NYSE">DPZ</a>) gained 14.1% to $536.50 after the company reported better-than-expected Q2 results and announced a $1 billion buyback.</li>
	<li>Co-Diagnostics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CODX#NASDAQ">CODX</a>) surged 12% to $9.74. Co-Diagnostics highlighted new international CoPrimer patent.</li>
	<li>SigmaTron International Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGMA#NASDAQ">SGMA</a>) shares gained 11.7% to $6.08 after the company reported fourth-quarter FY21 revenue growth of 17.4% year-on-year to $76 million.</li>
	<li>Zovio Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZVO#NASDAQ">ZVO</a>) gained 11.9% to $2.91.</li>
	<li>Arvinas, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARVN#NASDAQ">ARVN</a>) gained 10.3% to $85.55 after the company announced a global collaboration with Pfizer to develop and commercialize PROTAC protein degrader ARV-471.</li>
</ul>

<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>

<h3>Losers</h3>

<ul>
	<li>Sentage Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNTG#NASDAQ">SNTG</a>) fell 63.5% to $11.35. The company, earlier during the month, priced its IPO at $5 per share.</li>
	<li>Seres Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCRB#NASDAQ">MCRB</a>) shares dipped 54.3% to $9.53 after the company announced topline results from the Phase 2b ECO-RESET study evaluating SER-287 in patients with mild-to-moderate ulcerative colitis (UC). The study did not meet its primary endpoint of improving clinical remission rates compared to placebo.</li>
	<li>Twin Vee Powercats Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEEE#NASDAQ">VEEE</a>) fell 24% to $5.69. Twin Vee PowerCats jumped around 25% on Wednesday as the company priced its IPO at $6 per share.</li>
	<li>TRACON Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCON#NASDAQ">TCON</a>) fell 23.3% to $3.78 after the company announced it increased a previously announced bought deal offering of common stock to $15 million.</li>
	<li>Jupiter Wellness, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JUPW#NASDAQ">JUPW</a>) fell 22.8% to $2.1550 after the company announced pricing of a $32.5 million underwritten public offering of common stock and warrants.</li>
	<li>Mer Telemanagement Solutions Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSL#NASDAQ">MTSL</a>) dipped 20% to $3.8601 after the company announced shareholder approval of the merger with SharpLink and related transaction.</li>
	<li>Evelo Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVLO#NASDAQ">EVLO</a>) fell 19.8% to $10.34.</li>
	<li>Finch Therapeutics Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FNCH#NASDAQ">FNCH</a>) dropped 19.1% to $13.02.</li>
	<li>Kaleido Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLDO#NASDAQ">KLDO</a>) fell 16.7% to $6.07.</li>
	<li>Zenvia Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZENV#NASDAQ">ZENV</a>) dropped 16.6% to $10.84 as the company priced its IPO at $13 a share.</li>
	<li>InspireMD Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSPR#NYSE">NSPR</a>) fell 14.6% to $4.77 after surging over 29% on Wednesday.</li>
	<li>Stryve Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNAX#NASDAQ">SNAX</a>) dipped 14.5% to $7.95.</li>
	<li>Daqo New Energy Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DQ#NYSE">DQ</a>) fell 14% to $68.26, reversing from session highs after the company reported its subsidiary Xinjiang Daqo completed its IPO process and started trading on the Shanghai Stock Exchange.</li>
	<li>Forte Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FBRX#NASDAQ">FBRX</a>) dropped 13.6% to $31.65.</li>
	<li>Auddia Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) dipped 12.4% to $3.23.</li>
	<li>Marin Software Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) shares fell 11.7% to $8.61 after jumping over 24% on Wednesday.</li>
	<li>NetGear, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTGR#NASDAQ">NTGR</a>) fell 10.3% to $33.25 after the company reported worse-than-expected Q2 results and issued Q3 sales guidance below estimates.</li>
	<li>Lexaria Bioscience Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEXX#NASDAQ">LEXX</a>) shares fell 10.2% to $7.58. Lexaria Bioscience shares gained 28% on Wednesday after the company announced that its tolerability and pharmacokinetic study VIRAL-A20-3 has been completed with positive results..</li>
	<li>DiDi Global Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIDI#NYSE">DIDI</a>) dipped 10% to $10.35 following a Bloomberg report suggesting China said to weigh unprecedented penalty for DiDi after IPO.</li>
	<li>UNILEVER N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UL#NYSE">UL</a>) fell 5% to $55.81 after the company reported quarterly results.</li>
	<li>Texas Instruments Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) fell 4.8% to $185.06. Texas Instruments reported upbeat earnings for its second quarter. The company said it projects Q3 earnings of $1.87 to $2.13 per share on revenue of $4.4 billion to $4.76 billion.</li>
</ul>

38 Stocks Moving In Thursday's Mid-Day Session

<h3>Gainers</h3>
<ul>
<li>Socket Mobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCKT#NASDAQ">SCKT</a>) stock increased by 46.72% to $8.51 during Thursday's after-market session. Socket Mobile's trading volume hit 640.4K shares by close, accounting for 543.11% of its average volume over the last 100 days. The company's market cap stands at $60.6 million. As per the press release, Q2 earnings came out today. </li>
<li>Clearfield (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLFD#NASDAQ">CLFD</a>) shares moved upwards by 11.63% to $40.49. The company's market cap stands at $556.0 million. The company's, Q3 earnings came out today. </li>
<li>Auddia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) stock increased by 3.17% to $3.25. The company's market cap stands at $40.1 million. </li>
<li>Quantum Computing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) shares moved upwards by 2.94% to $9.1. The company's market cap stands at $262.5 million. </li>
<li>Oblong (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OBLG#NASDAQ">OBLG</a>) shares rose 2.29% to $2.67. The market value of their outstanding shares is at $81.7 million. </li>
<li>Ouster (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OUST#NYSE">OUST</a>) stock increased by 2.27% to $9.9. The market value of their outstanding shares is at $1.5 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Data Storage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTST#NASDAQ">DTST</a>) shares decreased by 7.0% to $4.65 during Thursday's after-market session. Trading volume for this security closed at 111.9K, accounting for 9.49% of its average full-day volume over the last 100 days. The company's market cap stands at $22.5 million. </li>
<li>Sigmatron International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGMA#NASDAQ">SGMA</a>) stock declined by 3.82% to $6.8. At the close, Sigmatron International's trading volume reached 223.0K shares. This is 143.74% of its average volume over the last 100 days. The market value of their outstanding shares is at $28.9 million. </li>
<li>Summit Wireless (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WISA#NASDAQ">WISA</a>) stock fell 3.26% to $4.45. This security traded at a volume of 191.0K shares come close, making up 19.31% of its average volume over the last 100 days. The market value of their outstanding shares is at $56.7 million. </li>
<li>VeriSign (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRSN#NASDAQ">VRSN</a>) stock declined by 2.23% to $228.33. Trading volume for this security closed at 159.1K, accounting for 30.14% of its average full-day volume over the last 100 days. The company's market cap stands at $25.7 billion. As per the press release, Q2 earnings came out today. </li>
<li>Intel (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) shares fell 1.9% to $54.9. Intel's trading volume hit 2.6 million shares by close, accounting for 10.58% of its average volume over the last 100 days. The company's market cap stands at $221.6 billion. The company's, Q2 earnings came out today. </li>
<li>Fiserv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FISV#NASDAQ">FISV</a>) shares decreased by 1.43% to $108.48. The company's market cap stands at $71.7 billion. </li>
</ul>

<h3>Gainers</h3>

<ul>
	<li>ImmunoPrecise Antibodies Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPA#NASDAQ">IPA</a>) shares jumped 138.2% to close at $13.22 on Thursday after the company announced new results from its TATX-03 PolyTope Therapy, demonstrating potent pseudovirus neutralizing activity against the SARS-CoV-2 Delta (B.1.617.2) variant.</li>
	<li>NRx Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRXP#NASDAQ">NRXP</a>) shares gained 62.7% to settle at $16.45 as the company said it has validated the first commercial formulation of Zyesami for intravenous use, allowing for high volume manufacturing, with an anticipated one year or greater stability under appropriate storage conditions.</li>
	<li>Universe Pharmaceuticals INC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) surged 44.5% to close at $3.83 on above-average volume.</li>
	<li>Absci Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABSI#NASDAQ">ABSI</a>) gained 34.9% to close at $21.59 after the company priced its IPO at $16 per share.</li>
	<li>SigmaTron International Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGMA#NASDAQ">SGMA</a>) shares jumped 30% to close at $7.07 after the company reported fourth-quarter FY21 revenue growth of 17.4% year-on-year to $76 million.</li>
	<li>PainReform Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRFX#NASDAQ">PRFX</a>) shares rose 29.9% to close at $4.08 on abnormally-high volume.</li>
	<li>Couchbase, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BASE#NASDAQ">BASE</a>) surged 26.7% to settle at $30.40 as the company priced its IPO at $24 per share.</li>
	<li>Co-Diagnostics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CODX#NASDAQ">CODX</a>) gained 21.2% to close at $10.54. Co-Diagnostics highlighted new international CoPrimer patent.</li>
	<li>Data Storage Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTST#NASDAQ">DTST</a>) surged 19.6% to close at $5.00.</li>
	<li>Neurometrix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NURO#NASDAQ">NURO</a>) jumped 18.9% to settle at $24.73 after reporting Q2 earnings. The company recently announced that its Quell device has received Breakthrough Designation from the FDA for treating the symptoms of fibromyalgia in adults.</li>
	<li>Applied DNA Sciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APDN#NASDAQ">APDN</a>) climbed 18% to close at $6.48.</li>
	<li>VTEX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTEX#NYSE">VTEX</a>) jumped 17.2% to settle at $26.00. VTEX recently priced 19 million shares at $19 per share in its initial public offering.</li>
	<li>The Beachbody Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BODY#NYSE">BODY</a>) gained 17.2% to settle at $10.72 amid interest on Reddit&rsquo;s r/WallStreetBets forum.</li>
	<li>ERYTECH Pharma S.A. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERYP#NASDAQ">ERYP</a>) climbed 17% to close at $5.10. ERYTECH recently confirmed plans to submit Biologics License Application for eryaspase in hypersensitive ALL patients.</li>
	<li>Aridis Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARDS#NASDAQ">ARDS</a>) gained 15.4% to settle at $5.85. Aridis Pharmaceuticals recently entered into an exclusive, worldwide licensing agreement with AstraZeneca to in-license the late-stage monoclonal antibody candidate, suvratoxumab for prevention of pneumonia.</li>
	<li>Battalion Oil Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BATL#NYSE">BATL</a>) gained 15.4% to settle at $13.20.</li>
	<li>Eastside Distilling, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EAST#NASDAQ">EAST</a>) rose 14.8% to close at $4.38.</li>
	<li>OptimumBank Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPHC#NASDAQ">OPHC</a>) gained 14.7% to close at $6.80.</li>
	<li>Domino&#39;s Pizza, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NYSE">DPZ</a>) surged 14.6% to close at $538.82 after the company reported better-than-expected Q2 results and announced a $1 billion buyback.</li>
	<li>Dawson Geophysical Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DWSN#NASDAQ">DWSN</a>) gained 14.6% to settle at $2.9674.</li>
	<li>Resources Connection, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGP#NYSE">RGP</a>) rose 14.2% to settle at $15.72 following a rise in quarterly earnings.</li>
	<li>Convey Holding Parent, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNVY#NYSE">CNVY</a>) gained 13.6% to close at $9.07.</li>
	<li>Acutus Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFIB#NASDAQ">AFIB</a>) rose 13.3% to settle at $16.33. Kerrisdale Advisers recently reported in a 13G filing a 5.25% stake in the company.</li>
	<li>Summit Wireless Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WISA#NASDAQ">WISA</a>) jumped 13% to close at $4.60 after the company highlighted the launch of its Amazon storefront.</li>
	<li>Sequential Brands Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SQBG#NASDAQ">SQBG</a>) gained 12.9% to close at $11.72.</li>
	<li>Support.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPRT#NASDAQ">SPRT</a>) gained 10.7% to close at $5.48 on above-average volume.</li>
	<li>F45 Training Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FXLV#NYSE">FXLV</a>) shares rose 10.3% to settle at $15.70. F45 Training Holdings recently reported closing of Initial Public Offering.</li>
	<li>Crocs, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CROX#NYSE">CROX</a>) gained 9.9% to settle at $131.93 after the company reported better-than-expected Q2 results and issued Q3 guidance.</li>
	<li>Arvinas, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARVN#NASDAQ">ARVN</a>) gained 9% to close at $84.51 after the company announced a global collaboration with Pfizer to develop and commercialize PROTAC protein degrader ARV-471.</li>
	<li>Zovio Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZVO#NASDAQ">ZVO</a>) rose 7.7% to close at $2.80.</li>
	<li>Papa John&#39;s International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PZZA#NASDAQ">PZZA</a>) gained 6.8% to settle at $119.27 in sympathy its peer, Domino&#39;s, which reported better-than-expected Q2 results.</li>
</ul>

 
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>

<h3>Losers</h3>

<ul>
	<li>Sentage Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNTG#NASDAQ">SNTG</a>) shares dipped 62.9% to close at $11.55 on Thursday. The company, earlier during the month, priced its IPO at $5 per share.</li>
	<li>Seres Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCRB#NASDAQ">MCRB</a>) shares fell 61.8% to settle at $7.95 after the company announced topline results from the Phase 2b ECO-RESET study evaluating SER-287 in patients with mild-to-moderate ulcerative colitis (UC). The study did not meet its primary endpoint of improving clinical remission rates compared to placebo.</li>
	<li>Jupiter Wellness, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JUPW#NASDAQ">JUPW</a>) dropped 26.9% to close at $2.04 after the company announced pricing of a $32.5 million underwritten public offering of common stock and warrants.</li>
	<li>TRACON Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCON#NASDAQ">TCON</a>) dipped 24.5% to close at $3.72 after the company announced it increased a previously announced bought deal offering of common stock to $15 million.</li>
	<li>Mer Telemanagement Solutions Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSL#NASDAQ">MTSL</a>) fell 23.8% to settle at $3.68 after the company announced shareholder approval of the merger with SharpLink and related transaction.</li>
	<li>Twin Vee Powercats Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEEE#NASDAQ">VEEE</a>) fell 23.4% to close at $5.74. Twin Vee PowerCats jumped around 25% on Wednesday as the company priced its IPO at $6 per share.</li>
	<li>Aehr Test Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHR#NASDAQ">AEHR</a>) dropped 22.9% to settle at $6.20.</li>
	<li>Evelo Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVLO#NASDAQ">EVLO</a>) fell 22.7% to close at $9.97.</li>
	<li>Zenvia Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZENV#NASDAQ">ZENV</a>) declined 21.5% to close at $10.20 as the company priced its IPO at $13 a share.</li>
	<li>Chembio Diagnostics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEMI#NASDAQ">CEMI</a>) fell 19.3% to settle at $4.31. Chembio Diagnostics received $4 million HIV test purchase order supported by The Global Fund.</li>
	<li>Finch Therapeutics Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FNCH#NASDAQ">FNCH</a>) dipped 17.3% to close at $13.31.</li>
	<li>InspireMD Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSPR#NYSE">NSPR</a>) fell 17% to close at $4.64 after surging over 29% on Wednesday.</li>
	<li>Capital Senior Living Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CSU#NYSE">CSU</a>) dipped 15.6% to close at $36.28.</li>
	<li>Kaleido Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLDO#NASDAQ">KLDO</a>) declined 15.1% to settle at $6.19.</li>
	<li>Daqo New Energy Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DQ#NYSE">DQ</a>) declined 14.8% to settle at $67.67, reversing from session highs after the company reported its subsidiary Xinjiang Daqo completed its IPO process and started trading on the Shanghai Stock Exchange.</li>
	<li>Auddia Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) slipped 14.6% to settle at $3.15.</li>
	<li>Verb Technology Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERB#NASDAQ">VERB</a>) fell 14.5% to close at $2.36.</li>
	<li>Nova LifeStyle, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVFY#NASDAQ">NVFY</a>) shares dropped 13.6% to settle at $3.49.</li>
	<li>Marin Software Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) shares declined 12.9% to close at $8.49 after jumping over 24% on Wednesday.</li>
	<li>Lexaria Bioscience Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEXX#NASDAQ">LEXX</a>) shares fell 12.4% to close at $7.39. Lexaria Bioscience shares gained 28% on Wednesday after the company announced that its tolerability and pharmacokinetic study VIRAL-A20-3 has been completed with positive results..</li>
	<li>Stryve Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNAX#NASDAQ">SNAX</a>) fell 12.3% to close at $8.16.</li>
	<li>SGOCO Group, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGOC#NASDAQ">SGOC</a>) dipped 12.3% to close at $9.87.</li>
	<li>Selecta Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SELB#NASDAQ">SELB</a>) dropped 12.3% to settle at $3.36.</li>
	<li>Harpoon Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HARP#NASDAQ">HARP</a>) fell 11.7% to close at $11.12.</li>
	<li>DiDi Global Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIDI#NYSE">DIDI</a>) declined 11.3% to close at $10.20 following a Bloomberg report suggesting China said to weigh unprecedented penalty for DiDi after IPO.</li>
	<li>Forte Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FBRX#NASDAQ">FBRX</a>) fell 10.9% to settle at $32.68.</li>
	<li>Community Health Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) dropped 9.9% to close at $14.28.</li>
	<li>The company is expected to release quarterly earnings on July 28.</li>
	<li>NetGear, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTGR#NASDAQ">NTGR</a>) fell 9.5% to close at $33.53 after the company reported worse-than-expected Q2 results and issued Q3 sales guidance below estimates.</li>
	<li>UNILEVER N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UL#NYSE">UL</a>) dropped 5.4% to close at $55.52 after the company reported quarterly results.</li>
	<li>Texas Instruments Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) fell 5.3% to settle at $183.91. Texas Instruments reported upbeat earnings for its second quarter. The company said it projects Q3 earnings of $1.87 to $2.13 per share on revenue of $4.4 billion to $4.76 billion.</li>
</ul>

Q1 2021		Est.		Actual		Surprise
EPS				-1.720
REV				0

Recent Quotes

Earnings

Related Companies

Auddia Frequently Asked Questions

How do I buy Auddia (AUUD) stock?

Who are Auddia's (AUUD) competitors?

What is the target price for Auddia (AUUD) stock?

Current Stock Price for Auddia (AUUD)?

Does Auddia (AUUD) pay a dividend?

When is Auddia (NASDAQ:AUUD) reporting earnings?

Is Auddia (AUUD) going to split?

What sector and industry does Auddia (AUUD) operate in?